data_2lug_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lug _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.459 -0.557 0 N-CA-C 111.146 -0.367 . . . . 50.509999999999998 111.146 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.97 -42.17 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 50.509999999999998 111.211 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.5 -39.84 86.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 50.509999999999998 111.191 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -58.48 -45.08 89.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 50.509999999999998 111.217 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -63.47 -42.36 98.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 50.509999999999998 111.15 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -55.35 -48.87 73.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 50.509999999999998 111.18 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.98 -31.87 73.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 50.509999999999998 111.179 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -60.76 -35.06 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 50.549999999999997 111.167 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.06 -45.02 31.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 50.509999999999998 111.235 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 50.509999999999998 111.188 -168.207 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo . . . . . 0 N--CA 1.458 -0.605 0 N-CA-C 111.232 -0.334 . . . . 50.509999999999998 111.232 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.1 t -69.12 -39.91 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 50.509999999999998 111.19 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.5 t -62.36 -42.82 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 50.509999999999998 111.179 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -62.83 -39.79 95.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 50.509999999999998 111.237 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -58.66 -44.59 90.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 50.509999999999998 111.21 174.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -64.04 -37.28 86.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 50.509999999999998 111.227 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -70.78 -28.56 64.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 50.509999999999998 111.14 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -74.99 -9.47 58.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 50.549999999999997 111.196 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.4 -45.45 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 50.509999999999998 111.212 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 50.509999999999998 111.205 -172.701 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 N--CA 1.458 -0.587 0 N-CA-C 111.213 -0.341 . . . . 50.509999999999998 111.213 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.57 -40.09 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 50.509999999999998 111.16 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.9 t -62.72 -39.93 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 50.509999999999998 111.211 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -73.23 -29.3 62.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 50.509999999999998 111.188 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -59.53 -50.24 74.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 50.509999999999998 111.206 172.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -55.51 -49.91 71.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 50.509999999999998 111.189 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -64.98 -30.27 71.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 50.509999999999998 111.19 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -65.74 -29.98 70.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 50.549999999999997 111.179 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.1 -45.05 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 50.509999999999998 111.298 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 50.509999999999998 111.203 -170.636 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 N--CA 1.457 -0.619 0 N-CA-C 111.206 -0.344 . . . . 50.509999999999998 111.206 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.2 t -70.55 -41.36 78.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 50.509999999999998 111.194 173.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.35 -40.06 87.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 50.509999999999998 111.226 173.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -59.92 -45.26 93.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 50.509999999999998 111.261 175.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -55.51 -50.8 69.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 50.509999999999998 111.211 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.71 -49.63 76.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 50.509999999999998 111.217 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -69.25 -27.26 65.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 50.509999999999998 111.16 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -75.53 -7.68 54.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 50.549999999999997 111.206 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.51 -47.81 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 50.509999999999998 111.169 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 50.509999999999998 111.125 -174.725 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo . . . . . 0 N--CA 1.458 -0.588 0 N-CA-C 111.19 -0.35 . . . . 50.509999999999998 111.19 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.03 -39.93 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 50.509999999999998 111.235 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.0 t -69.86 -36.71 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.286 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -59.57 -43.87 93.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 50.509999999999998 111.2 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -59.57 -45.93 90.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 50.509999999999998 111.161 173.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -55.01 -45.05 75.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 50.509999999999998 111.189 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.9 -34.76 78.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 50.509999999999998 111.233 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -59.87 -34.7 73.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 50.549999999999997 111.173 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.87 -43.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 50.509999999999998 111.189 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.5 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 50.509999999999998 111.153 -171.305 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 N--CA 1.458 -0.603 0 N-CA-C 111.19 -0.35 . . . . 50.509999999999998 111.19 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.58 -40.94 85.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 50.509999999999998 111.186 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.86 -41.15 91.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 50.509999999999998 111.263 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -65.77 -36.56 83.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 50.509999999999998 111.23 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -56.27 -50.7 70.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 50.509999999999998 111.196 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -57.36 -48.58 78.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 50.509999999999998 111.234 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -65.03 -30.41 71.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 50.509999999999998 111.222 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.0 -12.17 60.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 50.549999999999997 111.23 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 94.7 mt -90.83 -44.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 50.509999999999998 111.143 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 50.509999999999998 111.143 -174.78 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo . . . . . 0 N--CA 1.459 -0.539 0 N-CA-C 111.218 -0.339 . . . . 50.509999999999998 111.218 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.3 t -69.97 -45.09 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 50.509999999999998 111.144 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.56 -38.51 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 50.509999999999998 111.201 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -65.21 -40.09 93.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 50.509999999999998 111.173 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.42 -47.16 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 50.509999999999998 111.21 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -56.26 -47.94 77.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 50.509999999999998 111.154 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -60.25 -33.92 72.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 50.509999999999998 111.273 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.41 -34.41 76.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 50.549999999999997 111.212 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.09 -47.93 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.188 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.0 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 50.509999999999998 111.195 -171.807 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.458 -0.576 0 N-CA-C 111.173 -0.357 . . . . 50.509999999999998 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.92 -40.23 76.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 50.509999999999998 111.17 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.32 -39.92 87.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.231 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -60.59 -47.09 87.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 50.509999999999998 111.184 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -55.96 -52.22 64.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.232 176.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -51.74 -50.63 60.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 50.509999999999998 111.208 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -66.51 -29.96 70.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 50.509999999999998 111.223 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -73.52 -13.79 61.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 50.549999999999997 111.215 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.4 -45.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.185 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 50.509999999999998 111.206 -171.436 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo . . . . . 0 N--CA 1.458 -0.586 0 N-CA-C 111.169 -0.358 . . . . 50.509999999999998 111.169 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.4 t -62.25 -40.02 86.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.239 -0.437 . . . . 50.509999999999998 111.146 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 75.7 t -68.07 -41.2 84.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 50.509999999999998 111.136 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -54.97 -45.42 74.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 50.509999999999998 111.167 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -62.76 -45.65 91.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 50.509999999999998 111.218 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -55.0 -50.25 69.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 50.509999999999998 111.219 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -61.95 -39.97 93.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.167 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -64.08 -28.23 69.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 50.549999999999997 111.157 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.53 -47.31 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 50.509999999999998 111.213 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.2 m . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.196 -0.457 . . . . 50.509999999999998 111.216 -168.639 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 N--CA 1.459 -0.533 0 N-CA-C 111.176 -0.356 . . . . 50.509999999999998 111.176 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.1 t -65.35 -32.15 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 50.509999999999998 111.229 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.14 -40.4 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 50.509999999999998 111.148 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -76.16 -23.79 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 50.509999999999998 111.199 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -70.21 -40.99 74.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 50.509999999999998 111.23 171.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -57.06 -44.97 83.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 50.509999999999998 111.258 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.54 -37.71 82.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 50.509999999999998 111.226 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.0 -32.3 73.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 50.549999999999997 111.248 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.0 mt -72.47 -46.14 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 50.509999999999998 111.168 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 50.509999999999998 111.104 -170.01 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.812 0.339 . . . . 50.509999999999998 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -100.09 160.04 14.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 50.549999999999997 111.211 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -103.48 145.36 30.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 50.509999999999998 111.177 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.87 -161.77 33.88 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.2 -0.76 . . . . 50.509999999999998 111.2 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -105.74 13.8 29.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.343 . . . . 50.640000000000001 111.229 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.9 m -99.34 139.99 34.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 50.509999999999998 111.208 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.23 139.79 58.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 50.549999999999997 111.204 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -46.82 110.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 50.619999999999997 111.228 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -74.36 130.1 39.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 50.619999999999997 111.183 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 99.1 m-20 -75.07 148.95 84.75 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 50.549999999999997 111.21 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 10' ' ' ASN . 36.4 Cg_endo -62.86 -28.2 75.51 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.691 1.594 . . . . 50.509999999999998 111.146 177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.97 -42.17 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 50.509999999999998 111.211 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.5 -39.84 86.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 50.509999999999998 111.191 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -58.48 -45.08 89.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 50.509999999999998 111.217 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -63.47 -42.36 98.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 50.509999999999998 111.15 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -55.35 -48.87 73.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 50.509999999999998 111.18 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.98 -31.87 73.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 50.509999999999998 111.179 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -60.76 -35.06 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 50.549999999999997 111.167 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.06 -45.02 31.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 50.509999999999998 111.235 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m -96.08 -16.91 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 50.509999999999998 111.188 -168.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.9 m -126.83 120.12 22.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 50.509999999999998 111.192 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.91 -25.1 20.24 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.672 1.581 . . . . 50.509999999999998 111.235 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.15 139.72 41.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 50.640000000000001 111.26 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.432 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 91.5 m -56.59 117.58 17.76 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 50.509999999999998 111.184 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 24' ' ' THR . 41.4 Cg_exo -59.59 156.81 34.93 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.734 1.623 . . . . 50.509999999999998 111.172 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.56 154.87 72.35 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.701 1.601 . . . . 50.509999999999998 111.213 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.49 158.54 50.94 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.718 1.612 . . . . 50.509999999999998 111.198 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.1 m -68.73 144.17 54.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 50.509999999999998 111.205 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -104.97 161.92 13.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 50.549999999999997 111.223 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.81 147.81 43.15 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.19 -0.764 . . . . 50.509999999999998 111.19 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.1 121.41 14.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.809 0.337 . . . . 50.509999999999998 111.172 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.71 -5.05 56.6 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.203 -0.759 . . . . 50.509999999999998 111.203 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -67.23 -29.28 68.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.772 0.32 . . . . 50.640000000000001 111.186 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.73 -37.44 94.35 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.212 -0.755 . . . . 50.509999999999998 111.212 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.15 -31.99 38.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.74 0.305 . . . . 50.509999999999998 111.174 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.2 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 50.509999999999998 111.184 178.198 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.865 0.364 . . . . 50.509999999999998 111.219 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -98.12 159.26 15.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 50.549999999999997 111.226 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -66.39 136.82 56.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.208 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.49 -165.09 32.12 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.224 -0.75 . . . . 50.509999999999998 111.224 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -98.08 127.32 43.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 50.640000000000001 111.23 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.6 p -77.24 -17.16 58.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 50.509999999999998 111.19 -174.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -84.81 -36.47 21.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 50.549999999999997 111.197 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -95.1 -32.37 13.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 50.619999999999997 111.208 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -110.12 136.1 49.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 50.619999999999997 111.164 -175.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.414 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 99.5 m-20 -67.89 150.11 97.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 50.549999999999997 111.212 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 10' ' ' ASN . 38.5 Cg_endo -62.06 -24.38 76.54 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.721 1.614 . . . . 50.509999999999998 111.232 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.1 t -69.12 -39.91 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 50.509999999999998 111.19 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.5 t -62.36 -42.82 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 50.509999999999998 111.179 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -62.83 -39.79 95.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 50.509999999999998 111.237 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -58.66 -44.59 90.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 50.509999999999998 111.21 174.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -64.04 -37.28 86.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 50.509999999999998 111.227 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -70.78 -28.56 64.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 50.509999999999998 111.14 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -74.99 -9.47 58.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 50.549999999999997 111.196 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.4 -45.45 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 50.509999999999998 111.212 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.431 HG21 HG23 ' A' ' 21' ' ' THR . 34.2 m -87.52 -20.41 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 50.509999999999998 111.205 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.844 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 82.1 p -128.65 163.31 45.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 50.509999999999998 111.165 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.844 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 74.8 Cg_exo -53.72 147.25 41.11 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.685 1.59 . . . . 50.509999999999998 111.235 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -45.63 129.8 8.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 50.640000000000001 111.211 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.7 p -83.83 154.78 64.83 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 50.509999999999998 111.204 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.15 167.77 26.47 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.733 1.622 . . . . 50.509999999999998 111.162 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.33 159.18 20.07 Favored 'Trans proline' 0 C--N 1.328 -0.543 0 C-N-CA 121.724 1.616 . . . . 50.509999999999998 111.169 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.51 144.98 39.15 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.642 1.561 . . . . 50.509999999999998 111.24 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.3 m -95.84 130.03 42.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 50.509999999999998 111.224 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -74.96 123.93 26.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 50.549999999999997 111.232 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.5 22.28 58.75 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.218 -0.753 . . . . 50.509999999999998 111.218 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -119.84 20.43 12.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 50.509999999999998 111.179 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.07 -3.0 66.5 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.248 -0.741 . . . . 50.509999999999998 111.248 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -79.76 -25.97 40.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.359 . . . . 50.640000000000001 111.179 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.03 15.9 66.23 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.222 -0.751 . . . . 50.509999999999998 111.222 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.1 tp -67.49 121.57 16.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.76 0.314 . . . . 50.509999999999998 111.215 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.9 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 50.509999999999998 111.252 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.813 0.339 . . . . 50.509999999999998 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -67.4 112.38 4.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 50.549999999999997 111.155 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -73.88 124.19 25.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 50.509999999999998 111.22 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.99 -152.69 29.64 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.226 -0.75 . . . . 50.509999999999998 111.226 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -84.93 144.72 28.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.776 0.322 . . . . 50.640000000000001 111.225 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.4 p -85.35 152.08 23.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.2 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -83.95 146.65 27.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 50.549999999999997 111.246 -5.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -75.43 172.83 11.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 50.619999999999997 111.235 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.97 159.89 16.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 50.619999999999997 111.199 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -64.01 147.47 96.41 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 50.549999999999997 111.251 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -62.33 -25.04 76.22 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.735 1.623 . . . . 50.509999999999998 111.213 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.57 -40.09 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 50.509999999999998 111.16 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.9 t -62.72 -39.93 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 50.509999999999998 111.211 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -73.23 -29.3 62.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 50.509999999999998 111.188 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -59.53 -50.24 74.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 50.509999999999998 111.206 172.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -55.51 -49.91 71.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 50.509999999999998 111.189 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -64.98 -30.27 71.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 50.509999999999998 111.19 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -65.74 -29.98 70.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 50.549999999999997 111.179 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.1 -45.05 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 50.509999999999998 111.298 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.5 m -91.66 -15.74 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 50.509999999999998 111.203 -170.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.8 m -126.56 124.53 24.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 50.509999999999998 111.258 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.09 -25.98 21.95 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.672 1.581 . . . . 50.509999999999998 111.193 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.04 135.17 47.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 50.640000000000001 111.195 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.5 m -59.72 119.82 44.0 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 50.509999999999998 111.118 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.0 154.96 41.54 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.77 1.647 . . . . 50.509999999999998 111.167 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.66 162.1 6.99 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.702 1.602 . . . . 50.509999999999998 111.217 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.02 147.8 51.13 Favored 'Trans proline' 0 C--N 1.328 -0.543 0 C-N-CA 121.71 1.606 . . . . 50.509999999999998 111.183 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 94.3 p -82.61 165.01 20.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 50.509999999999998 111.21 -174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -47.36 127.02 10.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 50.549999999999997 111.14 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.64 -45.83 95.6 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.157 -0.777 . . . . 50.509999999999998 111.157 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.03 -34.79 78.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 50.509999999999998 111.232 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.71 -28.04 69.85 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.208 -0.757 . . . . 50.509999999999998 111.208 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -78.44 -35.06 47.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.822 0.344 . . . . 50.640000000000001 111.233 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.13 19.96 6.95 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.199 -0.76 . . . . 50.509999999999998 111.199 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -107.69 153.9 22.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.756 0.312 . . . . 50.509999999999998 111.217 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.447 . . . . 50.509999999999998 111.209 179.22 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.9 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.854 0.359 . . . . 50.509999999999998 111.203 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -68.65 128.76 37.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 50.549999999999997 111.184 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.513 ' HE2' ' HZ1' ' A' ' 17' ' ' LYS . 66.6 t-80 -63.01 134.98 57.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 50.509999999999998 111.174 174.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.43 176.0 48.36 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.21 -0.756 . . . . 50.509999999999998 111.21 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 61.6 ttm-85 -59.95 125.64 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.856 0.36 . . . . 50.640000000000001 111.224 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.666 ' HG1' ' HE2' ' A' ' 14' ' ' HIS . 77.2 p -77.85 160.9 28.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 50.509999999999998 111.176 -175.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -124.48 98.56 5.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 50.549999999999997 111.222 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.9 t0 52.6 46.37 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 50.619999999999997 111.183 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -100.02 158.97 15.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 50.619999999999997 111.202 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -70.75 148.85 95.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 50.549999999999997 111.181 -173.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.49 -24.99 55.9 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.685 1.59 . . . . 50.509999999999998 111.206 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.2 t -70.55 -41.36 78.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 50.509999999999998 111.194 173.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.35 -40.06 87.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 50.509999999999998 111.226 173.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.666 ' HE2' ' HG1' ' A' ' 6' ' ' THR . 63.8 m170 -59.92 -45.26 93.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 50.509999999999998 111.261 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -55.51 -50.8 69.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 50.509999999999998 111.211 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.71 -49.63 76.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 50.509999999999998 111.217 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.513 ' HZ1' ' HE2' ' A' ' 3' ' ' HIS . 94.8 mttt -69.25 -27.26 65.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 50.509999999999998 111.16 -173.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -75.53 -7.68 54.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 50.549999999999997 111.206 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.51 -47.81 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 50.509999999999998 111.169 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.87 -22.23 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 50.509999999999998 111.125 -174.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.793 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 82.3 p -133.51 163.47 50.86 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.203 172.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 50.2 Cg_exo -54.15 152.72 23.75 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.786 1.657 . . . . 50.509999999999998 111.185 175.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -49.95 122.51 6.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 50.640000000000001 111.23 -172.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.5 t -89.93 131.8 38.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 50.509999999999998 111.204 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.7 138.2 84.18 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.696 1.597 . . . . 50.509999999999998 111.201 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.66 161.66 36.49 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.739 1.626 . . . . 50.509999999999998 111.216 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.6 153.82 64.22 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.699 1.599 . . . . 50.509999999999998 111.208 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.1 p -79.99 170.08 16.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 50.509999999999998 111.183 174.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -78.68 150.04 32.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 50.549999999999997 111.157 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.95 -3.3 67.08 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.266 -0.733 . . . . 50.509999999999998 111.266 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -99.57 -3.89 32.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 50.509999999999998 111.165 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.36 -5.97 45.45 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.257 -0.737 . . . . 50.509999999999998 111.257 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -64.68 -44.96 88.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 50.640000000000001 111.244 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.3 -27.19 72.07 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.194 -0.762 . . . . 50.509999999999998 111.194 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.52 -29.99 52.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.795 0.331 . . . . 50.509999999999998 111.171 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 50.509999999999998 111.224 178.694 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.787 0.327 . . . . 50.509999999999998 111.158 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -69.5 150.05 47.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 50.549999999999997 111.209 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -74.97 160.59 30.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 50.509999999999998 111.244 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.88 -83.89 1.0 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.209 -0.756 . . . . 50.509999999999998 111.209 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -89.97 139.82 30.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 50.640000000000001 111.2 4.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 67.2 p -133.32 170.08 15.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 50.509999999999998 111.243 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -79.95 129.96 34.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 50.549999999999997 111.131 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -73.29 111.12 8.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 50.619999999999997 111.231 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -75.0 145.39 42.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 50.619999999999997 111.135 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.47 ' OD1' ' HD2' ' A' ' 11' ' ' PRO . 55.5 t-20 -75.01 119.64 77.88 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 50.549999999999997 111.165 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.47 ' HD2' ' OD1' ' A' ' 10' ' ' ASN . 71.3 Cg_exo -53.59 -31.73 60.92 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.713 1.609 . . . . 50.509999999999998 111.19 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.03 -39.93 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 50.509999999999998 111.235 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.0 t -69.86 -36.71 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.286 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -59.57 -43.87 93.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 50.509999999999998 111.2 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -59.57 -45.93 90.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 50.509999999999998 111.161 173.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -55.01 -45.05 75.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 50.509999999999998 111.189 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.9 -34.76 78.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 50.509999999999998 111.233 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -59.87 -34.7 73.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 50.549999999999997 111.173 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.87 -43.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 50.509999999999998 111.189 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.5 t -92.58 -62.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 50.509999999999998 111.153 -171.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.4 m -78.58 123.91 85.43 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 50.509999999999998 111.12 -172.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.41 143.08 38.12 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.714 1.609 . . . . 50.509999999999998 111.182 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 55.53 52.79 10.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 50.640000000000001 111.238 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.439 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 95.6 m -81.8 121.4 79.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 50.509999999999998 111.176 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 24' ' ' THR . 71.6 Cg_endo -76.32 165.47 29.27 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.702 1.601 . . . . 50.509999999999998 111.209 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.05 145.93 61.2 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.713 1.608 . . . . 50.509999999999998 111.186 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.51 140.34 32.91 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.714 1.609 . . . . 50.509999999999998 111.135 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 99.8 p -73.55 155.19 39.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 50.509999999999998 111.238 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -114.58 173.1 6.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.418 . . . . 50.549999999999997 111.217 -169.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.16 -164.96 38.27 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.153 -0.779 . . . . 50.509999999999998 111.153 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.07 125.04 22.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 50.509999999999998 111.198 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.92 -138.31 9.91 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.211 -0.756 . . . . 50.509999999999998 111.211 174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -145.32 115.12 7.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.826 0.345 . . . . 50.640000000000001 111.193 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.0 -21.53 67.88 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.198 -0.761 . . . . 50.509999999999998 111.198 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.96 -16.33 41.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 50.509999999999998 111.203 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 50.509999999999998 111.143 -178.715 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.805 0.336 . . . . 50.509999999999998 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -77.52 163.37 26.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 50.549999999999997 111.241 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -65.97 147.3 53.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.3 -0.409 . . . . 50.509999999999998 111.191 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.22 175.21 42.72 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.211 -0.755 . . . . 50.509999999999998 111.211 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -90.46 135.3 33.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.777 0.323 . . . . 50.640000000000001 111.156 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.3 m -65.57 -34.52 78.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.177 -0.465 . . . . 50.509999999999998 111.176 -175.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -67.44 -35.8 79.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 50.549999999999997 111.208 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -77.74 -41.73 36.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 50.619999999999997 111.16 -173.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -125.74 152.32 45.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 50.619999999999997 111.172 -175.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -66.62 146.61 99.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 50.549999999999997 111.206 -175.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.98 -24.75 59.89 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.764 1.643 . . . . 50.509999999999998 111.19 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.58 -40.94 85.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 50.509999999999998 111.186 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.86 -41.15 91.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 50.509999999999998 111.263 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -65.77 -36.56 83.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 50.509999999999998 111.23 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -56.27 -50.7 70.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 50.509999999999998 111.196 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -57.36 -48.58 78.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 50.509999999999998 111.234 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -65.03 -30.41 71.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 50.509999999999998 111.222 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.0 -12.17 60.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 50.549999999999997 111.23 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 94.7 mt -90.83 -44.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 50.509999999999998 111.143 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -88.91 -14.16 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 50.509999999999998 111.143 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.1 m -125.31 129.82 24.34 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.282 -0.417 . . . . 50.509999999999998 111.248 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.63 174.24 10.55 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.729 1.619 . . . . 50.509999999999998 111.148 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -59.81 120.12 8.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 50.640000000000001 111.201 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.629 ' HB ' ' CD ' ' A' ' 25' ' ' PRO . 76.7 p -127.98 166.09 26.11 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 50.509999999999998 111.184 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.629 ' CD ' ' HB ' ' A' ' 24' ' ' THR . 87.9 Cg_exo -53.16 145.3 43.86 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.716 1.61 . . . . 50.509999999999998 111.19 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.45 166.01 30.98 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.703 1.602 . . . . 50.509999999999998 111.212 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.96 169.11 22.96 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.698 1.599 . . . . 50.509999999999998 111.186 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.0 t -60.01 148.33 35.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 50.509999999999998 111.236 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -45.45 120.0 2.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 50.549999999999997 111.23 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.05 -82.07 1.06 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.19 -0.764 . . . . 50.509999999999998 111.19 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -98.88 158.25 15.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.723 0.297 . . . . 50.509999999999998 111.274 2.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.68 -164.64 32.97 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.243 -0.743 . . . . 50.509999999999998 111.243 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -80.12 -20.02 45.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 50.640000000000001 111.151 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.42 43.76 5.76 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.217 -0.753 . . . . 50.509999999999998 111.217 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.4 mt -114.49 -17.36 11.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 50.509999999999998 111.169 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 50.509999999999998 111.23 178.614 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.877 0.37 . . . . 50.509999999999998 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -73.07 129.77 38.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 50.549999999999997 111.217 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -112.42 170.02 8.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 50.509999999999998 111.199 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.03 152.43 43.83 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.143 -0.783 . . . . 50.509999999999998 111.143 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -76.88 -23.45 52.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 50.640000000000001 111.188 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 81.4 p -114.46 -10.61 12.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 50.509999999999998 111.256 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -99.97 -3.8 31.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 50.549999999999997 111.163 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -64.94 114.97 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 50.619999999999997 111.215 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -65.3 145.02 56.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 50.619999999999997 111.182 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.561 ' OD1' ' HD2' ' A' ' 11' ' ' PRO . 57.5 t-20 -54.07 120.88 26.97 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.492 . . . . 50.549999999999997 111.164 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.561 ' HD2' ' OD1' ' A' ' 10' ' ' ASN . 88.2 Cg_exo -52.03 -35.0 59.63 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.629 1.553 . . . . 50.509999999999998 111.218 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.3 t -69.97 -45.09 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 50.509999999999998 111.144 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.56 -38.51 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 50.509999999999998 111.201 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -65.21 -40.09 93.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 50.509999999999998 111.173 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.42 -47.16 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 50.509999999999998 111.21 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -56.26 -47.94 77.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 50.509999999999998 111.154 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -60.25 -33.92 72.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 50.509999999999998 111.273 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.41 -34.41 76.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 50.549999999999997 111.212 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.09 -47.93 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.188 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.0 m -90.77 -19.94 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 50.509999999999998 111.195 -171.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.44 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 39.1 m -133.97 93.39 20.34 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 50.509999999999998 111.218 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 21' ' ' THR . 77.7 Cg_exo -57.09 -27.68 75.2 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.692 1.595 . . . . 50.509999999999998 111.213 -175.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -109.95 30.72 6.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 50.640000000000001 111.189 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -64.21 140.06 97.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 50.509999999999998 111.223 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.64 154.22 64.4 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.733 1.622 . . . . 50.509999999999998 111.184 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.549 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 72.3 Cg_endo -74.6 171.45 18.14 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.677 1.584 . . . . 50.509999999999998 111.2 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 26' ' ' PRO . 74.3 Cg_exo -51.44 142.93 36.91 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.71 1.607 . . . . 50.509999999999998 111.23 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -75.06 151.11 38.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 50.509999999999998 111.126 -170.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -89.98 160.04 16.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 50.549999999999997 111.197 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.8 -153.26 30.12 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.171 -0.772 . . . . 50.509999999999998 111.171 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.11 -20.86 57.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 50.509999999999998 111.159 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.79 -178.61 51.65 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.202 -0.759 . . . . 50.509999999999998 111.202 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.35 152.5 26.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 50.640000000000001 111.194 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.06 -17.01 79.39 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.166 -0.773 . . . . 50.509999999999998 111.166 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.6 mt -96.99 -2.72 42.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.801 0.334 . . . . 50.509999999999998 111.186 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.22 -178.244 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.77 0.319 . . . . 50.509999999999998 111.19 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -70.03 127.94 34.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 50.549999999999997 111.207 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -55.51 128.49 34.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 50.509999999999998 111.206 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.72 -155.07 31.05 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.188 -0.765 . . . . 50.509999999999998 111.188 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -92.36 142.85 26.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 50.640000000000001 111.19 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.5 m -58.12 -40.3 80.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 50.509999999999998 111.169 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -74.9 -40.21 61.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 50.549999999999997 111.154 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -69.98 -49.78 48.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.416 . . . . 50.619999999999997 111.155 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -91.06 153.25 20.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 50.619999999999997 111.177 -166.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.439 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 99.1 m-20 -75.71 150.12 83.88 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 50.549999999999997 111.177 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 10' ' ' ASN . 36.4 Cg_endo -62.75 -25.62 74.92 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.77 1.647 . . . . 50.509999999999998 111.173 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.92 -40.23 76.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 50.509999999999998 111.17 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.32 -39.92 87.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.231 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -60.59 -47.09 87.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 50.509999999999998 111.184 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -55.96 -52.22 64.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.232 176.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -51.74 -50.63 60.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 50.509999999999998 111.208 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -66.51 -29.96 70.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 50.509999999999998 111.223 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -73.52 -13.79 61.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 50.549999999999997 111.215 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.4 -45.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.185 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.415 HG21 HG23 ' A' ' 21' ' ' THR . 33.3 m -87.16 -20.02 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 50.509999999999998 111.206 -171.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.869 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 66.6 p -129.58 163.22 48.13 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 50.509999999999998 111.248 171.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.869 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 73.5 Cg_exo -54.01 134.46 59.81 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.699 1.599 . . . . 50.509999999999998 111.158 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -49.96 119.92 3.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 50.640000000000001 111.23 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.1 m -115.87 119.79 36.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 50.509999999999998 111.218 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.81 120.07 7.51 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 121.742 1.628 . . . . 50.509999999999998 111.129 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.99 143.78 81.47 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.671 1.581 . . . . 50.509999999999998 111.219 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.71 155.0 59.23 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.734 1.623 . . . . 50.509999999999998 111.211 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.4 p -75.06 166.66 23.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 50.509999999999998 111.182 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -75.99 143.33 41.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 50.549999999999997 111.19 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.15 -3.8 67.01 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.226 -0.75 . . . . 50.509999999999998 111.226 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -90.93 154.94 19.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 50.509999999999998 111.206 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.02 161.59 51.02 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.145 -0.782 . . . . 50.509999999999998 111.145 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -67.21 -41.56 85.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 50.640000000000001 111.22 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -21.18 69.22 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.15 -0.78 . . . . 50.509999999999998 111.15 -171.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.07 -27.6 67.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.786 0.326 . . . . 50.509999999999998 111.157 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 50.509999999999998 111.192 179.619 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.805 0.336 . . . . 50.509999999999998 111.222 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -68.36 135.0 51.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 50.549999999999997 111.205 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -69.94 168.87 14.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 50.509999999999998 111.181 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.47 -177.21 45.74 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.164 -0.774 . . . . 50.509999999999998 111.164 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -70.63 169.43 14.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 50.640000000000001 111.169 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.2 m -65.02 -34.51 78.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 50.509999999999998 111.199 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -80.26 -37.71 32.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 50.549999999999997 111.21 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -77.67 -34.99 52.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 50.619999999999997 111.225 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -119.62 129.97 54.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 50.619999999999997 111.176 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -64.74 140.43 98.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 50.549999999999997 111.198 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.29 -36.73 69.11 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.694 1.596 . . . . 50.509999999999998 111.169 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.4 t -62.25 -40.02 86.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.239 -0.437 . . . . 50.509999999999998 111.146 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 75.7 t -68.07 -41.2 84.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 50.509999999999998 111.136 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -54.97 -45.42 74.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 50.509999999999998 111.167 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -62.76 -45.65 91.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 50.509999999999998 111.218 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -55.0 -50.25 69.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 50.509999999999998 111.219 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -61.95 -39.97 93.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.167 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -64.08 -28.23 69.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 50.549999999999997 111.157 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.53 -47.31 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 50.509999999999998 111.213 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.2 m -90.19 -12.48 9.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.196 -0.457 . . . . 50.509999999999998 111.216 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.821 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 19.0 p -116.36 165.88 13.93 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 50.509999999999998 111.179 172.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.821 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 50.1 Cg_exo -51.71 157.72 5.13 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.693 1.595 . . . . 50.509999999999998 111.185 171.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -49.84 120.03 4.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 50.640000000000001 111.224 -172.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.5 p -97.55 157.33 34.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 50.509999999999998 111.265 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.1 163.44 37.72 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.713 1.608 . . . . 50.509999999999998 111.186 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.24 161.71 43.72 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.695 1.597 . . . . 50.509999999999998 111.168 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.11 173.1 14.21 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.742 1.628 . . . . 50.509999999999998 111.164 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.8 p -77.73 169.97 17.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 50.509999999999998 111.234 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -66.02 117.07 7.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 50.549999999999997 111.196 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.04 -82.09 1.06 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.219 -0.752 . . . . 50.509999999999998 111.219 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.81 147.18 23.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.77 0.319 . . . . 50.509999999999998 111.231 1.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.87 -161.56 33.26 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.255 -0.738 . . . . 50.509999999999998 111.255 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.07 -30.0 55.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 50.640000000000001 111.249 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.93 22.42 52.87 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.112 -0.795 . . . . 50.509999999999998 111.112 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.5 mt -85.39 148.92 25.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.79 0.329 . . . . 50.509999999999998 111.172 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 50.509999999999998 111.223 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.829 0.347 . . . . 50.509999999999998 111.21 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -51.51 -48.04 63.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 50.549999999999997 111.248 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -115.92 -5.01 12.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 50.509999999999998 111.231 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.76 -25.6 66.91 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.179 -0.769 . . . . 50.509999999999998 111.179 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.64 -24.56 56.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.738 0.304 . . . . 50.640000000000001 111.221 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.8 p -85.02 168.86 14.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 50.509999999999998 111.163 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -66.36 135.42 54.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 50.549999999999997 111.251 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -58.89 118.87 6.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 50.619999999999997 111.185 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -91.29 150.18 21.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 50.619999999999997 111.189 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -80.11 129.17 70.97 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 50.549999999999997 111.179 172.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.78 -23.2 42.11 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.726 1.617 . . . . 50.509999999999998 111.176 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.1 t -65.35 -32.15 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 50.509999999999998 111.229 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.14 -40.4 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 50.509999999999998 111.148 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -76.16 -23.79 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 50.509999999999998 111.199 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -70.21 -40.99 74.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 50.509999999999998 111.23 171.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -57.06 -44.97 83.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 50.509999999999998 111.258 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.54 -37.71 82.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 50.509999999999998 111.226 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.0 -32.3 73.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 50.549999999999997 111.248 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.0 mt -72.47 -46.14 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 50.509999999999998 111.168 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m -90.23 -17.13 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 50.509999999999998 111.104 -170.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.3 m -122.24 123.78 27.08 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 50.509999999999998 111.205 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -70.16 -27.66 24.31 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.759 1.639 . . . . 50.509999999999998 111.182 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -74.97 136.17 41.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 50.640000000000001 111.179 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.9 m -58.72 120.07 42.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 50.509999999999998 111.24 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.79 159.44 42.03 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.648 1.565 . . . . 50.509999999999998 111.159 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.06 155.38 69.81 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.712 1.608 . . . . 50.509999999999998 111.195 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.47 155.77 50.33 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.709 1.606 . . . . 50.509999999999998 111.193 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.5 t -63.53 131.65 48.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 50.509999999999998 111.17 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -74.39 139.94 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 50.549999999999997 111.197 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.73 -148.37 38.28 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.234 -0.746 . . . . 50.509999999999998 111.234 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.91 134.29 53.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.824 0.345 . . . . 50.509999999999998 111.211 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.24 17.02 30.67 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.26 -0.736 . . . . 50.509999999999998 111.26 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -61.66 135.11 57.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.896 0.379 . . . . 50.640000000000001 111.166 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.31 -166.38 40.85 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.194 -0.762 . . . . 50.509999999999998 111.194 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.1 mt -104.3 2.35 31.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.771 0.32 . . . . 50.509999999999998 111.183 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.6 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 50.509999999999998 111.266 179.924 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.459 -0.557 0 N-CA-C 111.146 -0.367 . . . . 50.51 111.146 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.97 -42.17 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 50.51 111.211 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.5 -39.84 86.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 50.51 111.191 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -58.48 -45.08 89.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 50.51 111.217 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -63.47 -42.36 98.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 50.51 111.15 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -55.35 -48.87 73.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 50.51 111.18 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.98 -31.87 73.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 50.51 111.179 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -60.76 -35.06 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 50.55 111.167 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.06 -45.02 31.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 50.51 111.235 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 50.51 111.188 -168.207 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo . . . . . 0 N--CA 1.458 -0.605 0 N-CA-C 111.232 -0.334 . . . . 50.51 111.232 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.1 t -69.12 -39.91 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 50.51 111.19 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.5 t -62.36 -42.82 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 50.51 111.179 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -62.83 -39.79 95.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 50.51 111.237 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -58.66 -44.59 90.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 50.51 111.21 174.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -64.04 -37.28 86.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 50.51 111.227 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -70.78 -28.56 64.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 50.51 111.14 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -74.99 -9.47 58.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 50.55 111.196 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.4 -45.45 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 50.51 111.212 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 50.51 111.205 -172.701 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 N--CA 1.458 -0.587 0 N-CA-C 111.213 -0.341 . . . . 50.51 111.213 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.57 -40.09 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 50.51 111.16 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.9 t -62.72 -39.93 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 50.51 111.211 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -73.23 -29.3 62.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 50.51 111.188 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -59.53 -50.24 74.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 50.51 111.206 172.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -55.51 -49.91 71.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 50.51 111.189 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -64.98 -30.27 71.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 50.51 111.19 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -65.74 -29.98 70.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 50.55 111.179 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.1 -45.05 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 50.51 111.298 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 50.51 111.203 -170.636 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 N--CA 1.457 -0.619 0 N-CA-C 111.206 -0.344 . . . . 50.51 111.206 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.2 t -70.55 -41.36 78.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 50.51 111.194 173.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.35 -40.06 87.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 50.51 111.226 173.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -59.92 -45.26 93.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 50.51 111.261 175.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -55.51 -50.8 69.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 50.51 111.211 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.71 -49.63 76.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 50.51 111.217 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -69.25 -27.26 65.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 50.51 111.16 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -75.53 -7.68 54.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 50.55 111.206 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.51 -47.81 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 50.51 111.169 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 50.51 111.125 -174.725 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo . . . . . 0 N--CA 1.458 -0.588 0 N-CA-C 111.19 -0.35 . . . . 50.51 111.19 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.03 -39.93 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 50.51 111.235 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.0 t -69.86 -36.71 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 50.51 111.286 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -59.57 -43.87 93.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 50.51 111.2 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -59.57 -45.93 90.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 50.51 111.161 173.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -55.01 -45.05 75.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 50.51 111.189 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.9 -34.76 78.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 50.51 111.233 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -59.87 -34.7 73.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 50.55 111.173 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.87 -43.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 50.51 111.189 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.5 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 50.51 111.153 -171.305 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 N--CA 1.458 -0.603 0 N-CA-C 111.19 -0.35 . . . . 50.51 111.19 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.58 -40.94 85.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 50.51 111.186 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.86 -41.15 91.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 50.51 111.263 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -65.77 -36.56 83.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 50.51 111.23 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -56.27 -50.7 70.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 50.51 111.196 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -57.36 -48.58 78.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 50.51 111.234 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -65.03 -30.41 71.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 50.51 111.222 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.0 -12.17 60.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 50.55 111.23 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 94.7 mt -90.83 -44.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 50.51 111.143 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 50.51 111.143 -174.78 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo . . . . . 0 N--CA 1.459 -0.539 0 N-CA-C 111.218 -0.339 . . . . 50.51 111.218 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.3 t -69.97 -45.09 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 50.51 111.144 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.56 -38.51 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 50.51 111.201 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -65.21 -40.09 93.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 50.51 111.173 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.42 -47.16 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 50.51 111.21 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -56.26 -47.94 77.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 50.51 111.154 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -60.25 -33.92 72.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 50.51 111.273 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.41 -34.41 76.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 50.55 111.212 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.09 -47.93 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 50.51 111.188 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.0 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 50.51 111.195 -171.807 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.458 -0.576 0 N-CA-C 111.173 -0.357 . . . . 50.51 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.92 -40.23 76.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 50.51 111.17 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.32 -39.92 87.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 50.51 111.231 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -60.59 -47.09 87.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 50.51 111.184 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -55.96 -52.22 64.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 50.51 111.232 176.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -51.74 -50.63 60.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 50.51 111.208 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -66.51 -29.96 70.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 50.51 111.223 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -73.52 -13.79 61.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 50.55 111.215 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.4 -45.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 50.51 111.185 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 50.51 111.206 -171.436 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo . . . . . 0 N--CA 1.458 -0.586 0 N-CA-C 111.169 -0.358 . . . . 50.51 111.169 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.4 t -62.25 -40.02 86.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.239 -0.437 . . . . 50.51 111.146 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 75.7 t -68.07 -41.2 84.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 50.51 111.136 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -54.97 -45.42 74.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 50.51 111.167 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -62.76 -45.65 91.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 50.51 111.218 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -55.0 -50.25 69.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 50.51 111.219 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -61.95 -39.97 93.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 50.51 111.167 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -64.08 -28.23 69.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 50.55 111.157 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.53 -47.31 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 50.51 111.213 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.2 m . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.196 -0.457 . . . . 50.51 111.216 -168.639 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 N--CA 1.459 -0.533 0 N-CA-C 111.176 -0.356 . . . . 50.51 111.176 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.1 t -65.35 -32.15 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 50.51 111.229 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.14 -40.4 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 50.51 111.148 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -76.16 -23.79 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 50.51 111.199 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -70.21 -40.99 74.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 50.51 111.23 171.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -57.06 -44.97 83.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 50.51 111.258 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.54 -37.71 82.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 50.51 111.226 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.0 -32.3 73.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 50.55 111.248 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.0 mt -72.47 -46.14 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 50.51 111.168 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 50.51 111.104 -170.01 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.812 0.339 . . . . 50.51 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -100.09 160.04 14.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 50.55 111.211 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -103.48 145.36 30.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 50.51 111.177 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.87 -161.77 33.88 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.2 -0.76 . . . . 50.51 111.2 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -105.74 13.8 29.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.343 . . . . 50.64 111.229 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.521 ' HB ' ' HG3' ' A' ' 29' ' ' GLN . 91.9 m -99.34 139.99 34.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 50.51 111.208 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.23 139.79 58.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 50.55 111.204 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -46.82 110.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 50.62 111.228 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -74.36 130.1 39.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 50.62 111.183 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -75.07 148.95 84.75 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 50.55 111.21 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.86 -28.2 75.51 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.691 1.594 . . . . 50.51 111.146 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.97 -42.17 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 50.51 111.211 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.5 -39.84 86.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 50.51 111.191 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -58.48 -45.08 89.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 50.51 111.217 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -63.47 -42.36 98.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 50.51 111.15 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -55.35 -48.87 73.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 50.51 111.18 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.98 -31.87 73.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 50.51 111.179 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -60.76 -35.06 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 50.55 111.167 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.06 -45.02 31.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 50.51 111.235 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m -96.08 -16.91 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 50.51 111.188 -168.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.407 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 85.9 m -126.83 120.12 22.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 50.51 111.192 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 21' ' ' THR . 56.1 Cg_endo -71.91 -25.1 20.24 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.672 1.581 . . . . 50.51 111.235 -177.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.15 139.72 41.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 50.64 111.26 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 91.5 m -56.59 117.58 17.76 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 50.51 111.184 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 41.4 Cg_exo -59.59 156.81 34.93 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.734 1.623 . . . . 50.51 111.172 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.56 154.87 72.35 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.701 1.601 . . . . 50.51 111.213 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.49 158.54 50.94 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.718 1.612 . . . . 50.51 111.198 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.1 m -68.73 144.17 54.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 50.51 111.205 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.521 ' HG3' ' HB ' ' A' ' 6' ' ' THR . 89.4 mm-40 -104.97 161.92 13.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 50.55 111.223 -176.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.81 147.81 43.15 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.19 -0.764 . . . . 50.51 111.19 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.1 121.41 14.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.809 0.337 . . . . 50.51 111.172 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.71 -5.05 56.6 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.203 -0.759 . . . . 50.51 111.203 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -67.23 -29.28 68.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.772 0.32 . . . . 50.64 111.186 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.73 -37.44 94.35 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.212 -0.755 . . . . 50.51 111.212 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.15 -31.99 38.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.74 0.305 . . . . 50.51 111.174 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.2 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 50.51 111.184 178.198 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.865 0.364 . . . . 50.51 111.219 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -98.12 159.26 15.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 50.55 111.226 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -66.39 136.82 56.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 50.51 111.208 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.49 -165.09 32.12 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.224 -0.75 . . . . 50.51 111.224 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.418 ' HG2' ' H ' ' A' ' 7' ' ' GLN . 64.4 ttt180 -98.08 127.32 43.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 50.64 111.23 -177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.6 p -77.24 -17.16 58.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 50.51 111.19 -174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.418 ' H ' ' HG2' ' A' ' 5' ' ' ARG . 98.0 mm-40 -84.81 -36.47 21.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 50.55 111.197 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -95.1 -32.37 13.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 50.62 111.208 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -110.12 136.1 49.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 50.62 111.164 -175.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -67.89 150.11 97.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 50.55 111.212 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.06 -24.38 76.54 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.721 1.614 . . . . 50.51 111.232 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.1 t -69.12 -39.91 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 50.51 111.19 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.5 t -62.36 -42.82 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 50.51 111.179 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -62.83 -39.79 95.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 50.51 111.237 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -58.66 -44.59 90.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 50.51 111.21 174.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -64.04 -37.28 86.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 50.51 111.227 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -70.78 -28.56 64.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 50.51 111.14 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -74.99 -9.47 58.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 50.55 111.196 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.4 -45.45 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 50.51 111.212 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.433 HG23 HG23 ' A' ' 21' ' ' THR . 34.2 m -87.52 -20.41 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 50.51 111.205 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.503 ' HB ' ' CD ' ' A' ' 22' ' ' PRO . 82.1 p -128.65 163.31 45.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 50.51 111.165 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.503 ' CD ' ' HB ' ' A' ' 21' ' ' THR . 74.8 Cg_exo -53.72 147.25 41.11 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.685 1.59 . . . . 50.51 111.235 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -45.63 129.8 8.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 50.64 111.211 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.7 p -83.83 154.78 64.83 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 50.51 111.204 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.15 167.77 26.47 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.733 1.622 . . . . 50.51 111.162 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.33 159.18 20.07 Favored 'Trans proline' 0 C--N 1.328 -0.543 0 C-N-CA 121.724 1.616 . . . . 50.51 111.169 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.51 144.98 39.15 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.642 1.561 . . . . 50.51 111.24 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.3 m -95.84 130.03 42.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 50.51 111.224 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -74.96 123.93 26.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 50.55 111.232 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.5 22.28 58.75 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.218 -0.753 . . . . 50.51 111.218 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -119.84 20.43 12.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 50.51 111.179 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.07 -3.0 66.5 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.248 -0.741 . . . . 50.51 111.248 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -79.76 -25.97 40.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.359 . . . . 50.64 111.179 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.03 15.9 66.23 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.222 -0.751 . . . . 50.51 111.222 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.1 tp -67.49 121.57 16.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.76 0.314 . . . . 50.51 111.215 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.9 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 50.51 111.252 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.813 0.339 . . . . 50.51 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -67.4 112.38 4.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 50.55 111.155 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -73.88 124.19 25.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 50.51 111.22 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.99 -152.69 29.64 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.226 -0.75 . . . . 50.51 111.226 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -84.93 144.72 28.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.776 0.322 . . . . 50.64 111.225 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.4 p -85.35 152.08 23.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 50.51 111.2 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.572 ' HB3' ' HG3' ' A' ' 29' ' ' GLN . 92.6 mm-40 -83.95 146.65 27.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 50.55 111.246 -5.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -75.43 172.83 11.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 50.62 111.235 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.97 159.89 16.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 50.62 111.199 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -64.01 147.47 96.41 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 50.55 111.251 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -62.33 -25.04 76.22 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.735 1.623 . . . . 50.51 111.213 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.57 -40.09 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 50.51 111.16 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.9 t -62.72 -39.93 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 50.51 111.211 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -73.23 -29.3 62.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 50.51 111.188 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -59.53 -50.24 74.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 50.51 111.206 172.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -55.51 -49.91 71.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 50.51 111.189 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -64.98 -30.27 71.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 50.51 111.19 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -65.74 -29.98 70.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 50.55 111.179 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.1 -45.05 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 50.51 111.298 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.5 m -91.66 -15.74 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 50.51 111.203 -170.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.8 m -126.56 124.53 24.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 50.51 111.258 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.09 -25.98 21.95 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.672 1.581 . . . . 50.51 111.193 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.04 135.17 47.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 50.64 111.195 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.473 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 65.5 m -59.72 119.82 44.0 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 50.51 111.118 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 53.0 Cg_exo -59.0 154.96 41.54 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.77 1.647 . . . . 50.51 111.167 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 53.2 Cg_exo -55.66 162.1 6.99 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.702 1.602 . . . . 50.51 111.217 176.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.02 147.8 51.13 Favored 'Trans proline' 0 C--N 1.328 -0.543 0 C-N-CA 121.71 1.606 . . . . 50.51 111.183 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 94.3 p -82.61 165.01 20.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 50.51 111.21 -174.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.572 ' HG3' ' HB3' ' A' ' 7' ' ' GLN . 43.9 tt0 -47.36 127.02 10.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 50.55 111.14 175.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.64 -45.83 95.6 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.157 -0.777 . . . . 50.51 111.157 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.03 -34.79 78.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 50.51 111.232 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.71 -28.04 69.85 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.208 -0.757 . . . . 50.51 111.208 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -78.44 -35.06 47.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.822 0.344 . . . . 50.64 111.233 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.13 19.96 6.95 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.199 -0.76 . . . . 50.51 111.199 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -107.69 153.9 22.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.756 0.312 . . . . 50.51 111.217 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.447 . . . . 50.51 111.209 179.22 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.9 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.854 0.359 . . . . 50.51 111.203 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.461 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 65.2 tt0 -68.65 128.76 37.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 50.55 111.184 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -63.01 134.98 57.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 50.51 111.174 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.43 176.0 48.36 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.21 -0.756 . . . . 50.51 111.21 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 61.6 ttm-85 -59.95 125.64 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.856 0.36 . . . . 50.64 111.224 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 77.2 p -77.85 160.9 28.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 50.51 111.176 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -124.48 98.56 5.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 50.55 111.222 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.9 t0 52.6 46.37 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 50.62 111.183 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -100.02 158.97 15.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 50.62 111.202 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -70.75 148.85 95.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 50.55 111.181 -173.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.49 -24.99 55.9 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.685 1.59 . . . . 50.51 111.206 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.2 t -70.55 -41.36 78.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 50.51 111.194 173.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.35 -40.06 87.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 50.51 111.226 173.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -59.92 -45.26 93.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 50.51 111.261 175.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -55.51 -50.8 69.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 50.51 111.211 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.71 -49.63 76.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 50.51 111.217 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -69.25 -27.26 65.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 50.51 111.16 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -75.53 -7.68 54.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 50.55 111.206 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.51 -47.81 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 50.51 111.169 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.87 -22.23 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 50.51 111.125 -174.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.464 ' HB ' ' CD ' ' A' ' 22' ' ' PRO . 82.3 p -133.51 163.47 50.86 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 50.51 111.203 172.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.464 ' CD ' ' HB ' ' A' ' 21' ' ' THR . 50.2 Cg_exo -54.15 152.72 23.75 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.786 1.657 . . . . 50.51 111.185 175.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -49.95 122.51 6.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 50.64 111.23 -172.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.5 t -89.93 131.8 38.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 50.51 111.204 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.7 138.2 84.18 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.696 1.597 . . . . 50.51 111.201 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 74.0 Cg_endo -75.66 161.66 36.49 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.739 1.626 . . . . 50.51 111.216 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 26' ' ' PRO . 31.5 Cg_exo -61.6 153.82 64.22 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.699 1.599 . . . . 50.51 111.208 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.1 p -79.99 170.08 16.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 50.51 111.183 174.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -78.68 150.04 32.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 50.55 111.157 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.95 -3.3 67.08 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.266 -0.733 . . . . 50.51 111.266 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -99.57 -3.89 32.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 50.51 111.165 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.36 -5.97 45.45 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.257 -0.737 . . . . 50.51 111.257 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -64.68 -44.96 88.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 50.64 111.244 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.3 -27.19 72.07 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.194 -0.762 . . . . 50.51 111.194 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.52 -29.99 52.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.795 0.331 . . . . 50.51 111.171 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 50.51 111.224 178.694 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.787 0.327 . . . . 50.51 111.158 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -69.5 150.05 47.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 50.55 111.209 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.402 ' HA ' ' H ' ' A' ' 32' ' ' GLY . 52.8 p-80 -74.97 160.59 30.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 50.51 111.244 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.88 -83.89 1.0 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.209 -0.756 . . . . 50.51 111.209 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -89.97 139.82 30.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 50.64 111.2 4.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 67.2 p -133.32 170.08 15.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 50.51 111.243 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -79.95 129.96 34.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 50.55 111.131 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -73.29 111.12 8.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 50.62 111.231 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -75.0 145.39 42.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 50.62 111.135 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.446 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 55.5 t-20 -75.01 119.64 77.88 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 50.55 111.165 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 10' ' ' ASN . 71.3 Cg_exo -53.59 -31.73 60.92 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.713 1.609 . . . . 50.51 111.19 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.03 -39.93 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 50.51 111.235 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.0 t -69.86 -36.71 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 50.51 111.286 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -59.57 -43.87 93.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 50.51 111.2 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -59.57 -45.93 90.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 50.51 111.161 173.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -55.01 -45.05 75.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 50.51 111.189 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.9 -34.76 78.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 50.51 111.233 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -59.87 -34.7 73.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 50.55 111.173 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.87 -43.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 50.51 111.189 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.5 t -92.58 -62.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 50.51 111.153 -171.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.408 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 98.4 m -78.58 123.91 85.43 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 50.51 111.12 -172.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 21' ' ' THR . 63.9 Cg_endo -72.41 143.08 38.12 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.714 1.609 . . . . 50.51 111.182 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 55.53 52.79 10.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 50.64 111.238 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.407 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 95.6 m -81.8 121.4 79.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 50.51 111.176 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 24' ' ' THR . 71.6 Cg_endo -76.32 165.47 29.27 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.702 1.601 . . . . 50.51 111.209 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.05 145.93 61.2 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.713 1.608 . . . . 50.51 111.186 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.51 140.34 32.91 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.714 1.609 . . . . 50.51 111.135 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 99.8 p -73.55 155.19 39.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 50.51 111.238 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -114.58 173.1 6.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.418 . . . . 50.55 111.217 -169.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.16 -164.96 38.27 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.153 -0.779 . . . . 50.51 111.153 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.07 125.04 22.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 50.51 111.198 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.402 ' H ' ' HA ' ' A' ' 3' ' ' HIS . . . -102.92 -138.31 9.91 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.211 -0.756 . . . . 50.51 111.211 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -145.32 115.12 7.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.826 0.345 . . . . 50.64 111.193 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.0 -21.53 67.88 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.198 -0.761 . . . . 50.51 111.198 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.96 -16.33 41.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 50.51 111.203 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 50.51 111.143 -178.715 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.805 0.336 . . . . 50.51 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -77.52 163.37 26.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 50.55 111.241 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -65.97 147.3 53.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.3 -0.409 . . . . 50.51 111.191 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.22 175.21 42.72 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.211 -0.755 . . . . 50.51 111.211 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -90.46 135.3 33.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.777 0.323 . . . . 50.64 111.156 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.3 m -65.57 -34.52 78.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.177 -0.465 . . . . 50.51 111.176 -175.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -67.44 -35.8 79.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 50.55 111.208 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -77.74 -41.73 36.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 50.62 111.16 -173.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -125.74 152.32 45.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 50.62 111.172 -175.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -66.62 146.61 99.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 50.55 111.206 -175.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.98 -24.75 59.89 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.764 1.643 . . . . 50.51 111.19 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.58 -40.94 85.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 50.51 111.186 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.86 -41.15 91.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 50.51 111.263 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -65.77 -36.56 83.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 50.51 111.23 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -56.27 -50.7 70.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 50.51 111.196 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -57.36 -48.58 78.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 50.51 111.234 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -65.03 -30.41 71.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 50.51 111.222 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.0 -12.17 60.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 50.55 111.23 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 94.7 mt -90.83 -44.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 50.51 111.143 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -88.91 -14.16 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 50.51 111.143 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.1 m -125.31 129.82 24.34 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.282 -0.417 . . . . 50.51 111.248 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.63 174.24 10.55 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.729 1.619 . . . . 50.51 111.148 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -59.81 120.12 8.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 50.64 111.201 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.633 ' HB ' ' CD ' ' A' ' 25' ' ' PRO . 76.7 p -127.98 166.09 26.11 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 50.51 111.184 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.633 ' CD ' ' HB ' ' A' ' 24' ' ' THR . 87.9 Cg_exo -53.16 145.3 43.86 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.716 1.61 . . . . 50.51 111.19 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.45 166.01 30.98 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.703 1.602 . . . . 50.51 111.212 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.96 169.11 22.96 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.698 1.599 . . . . 50.51 111.186 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.0 t -60.01 148.33 35.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 50.51 111.236 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -45.45 120.0 2.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 50.55 111.23 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.05 -82.07 1.06 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.19 -0.764 . . . . 50.51 111.19 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -98.88 158.25 15.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.723 0.297 . . . . 50.51 111.274 2.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.68 -164.64 32.97 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.243 -0.743 . . . . 50.51 111.243 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -80.12 -20.02 45.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 50.64 111.151 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.42 43.76 5.76 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.217 -0.753 . . . . 50.51 111.217 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.4 mt -114.49 -17.36 11.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 50.51 111.169 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 50.51 111.23 178.614 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.877 0.37 . . . . 50.51 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -73.07 129.77 38.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 50.55 111.217 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -112.42 170.02 8.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 50.51 111.199 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.03 152.43 43.83 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.143 -0.783 . . . . 50.51 111.143 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -76.88 -23.45 52.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 50.64 111.188 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 81.4 p -114.46 -10.61 12.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 50.51 111.256 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -99.97 -3.8 31.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 50.55 111.163 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -64.94 114.97 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 50.62 111.215 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -65.3 145.02 56.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 50.62 111.182 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.482 ' OD1' ' HD2' ' A' ' 11' ' ' PRO . 57.5 t-20 -54.07 120.88 26.97 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.492 . . . . 50.55 111.164 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 10' ' ' ASN . 88.2 Cg_exo -52.03 -35.0 59.63 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.629 1.553 . . . . 50.51 111.218 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.3 t -69.97 -45.09 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 50.51 111.144 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.56 -38.51 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 50.51 111.201 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -65.21 -40.09 93.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 50.51 111.173 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.42 -47.16 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 50.51 111.21 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -56.26 -47.94 77.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 50.51 111.154 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -60.25 -33.92 72.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 50.51 111.273 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.41 -34.41 76.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 50.55 111.212 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.09 -47.93 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 50.51 111.188 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.0 m -90.77 -19.94 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 50.51 111.195 -171.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.1 m -133.97 93.39 20.34 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 50.51 111.218 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -57.09 -27.68 75.2 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.692 1.595 . . . . 50.51 111.213 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -109.95 30.72 6.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 50.64 111.189 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -64.21 140.06 97.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 50.51 111.223 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.64 154.22 64.4 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.733 1.622 . . . . 50.51 111.184 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.6 171.45 18.14 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.677 1.584 . . . . 50.51 111.2 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -51.44 142.93 36.91 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.71 1.607 . . . . 50.51 111.23 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -75.06 151.11 38.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 50.51 111.126 -170.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -89.98 160.04 16.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 50.55 111.197 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.8 -153.26 30.12 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.171 -0.772 . . . . 50.51 111.171 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.11 -20.86 57.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 50.51 111.159 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.79 -178.61 51.65 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.202 -0.759 . . . . 50.51 111.202 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.35 152.5 26.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 50.64 111.194 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.06 -17.01 79.39 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.166 -0.773 . . . . 50.51 111.166 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.6 mt -96.99 -2.72 42.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.801 0.334 . . . . 50.51 111.186 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 50.51 111.22 -178.244 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.77 0.319 . . . . 50.51 111.19 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -70.03 127.94 34.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 50.55 111.207 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -55.51 128.49 34.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 50.51 111.206 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.72 -155.07 31.05 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.188 -0.765 . . . . 50.51 111.188 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -92.36 142.85 26.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 50.64 111.19 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.5 m -58.12 -40.3 80.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 50.51 111.169 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -74.9 -40.21 61.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 50.55 111.154 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -69.98 -49.78 48.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.416 . . . . 50.62 111.155 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -91.06 153.25 20.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 50.62 111.177 -166.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -75.71 150.12 83.88 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 50.55 111.177 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.75 -25.62 74.92 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.77 1.647 . . . . 50.51 111.173 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.92 -40.23 76.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 50.51 111.17 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.32 -39.92 87.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 50.51 111.231 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -60.59 -47.09 87.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 50.51 111.184 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -55.96 -52.22 64.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 50.51 111.232 176.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -51.74 -50.63 60.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 50.51 111.208 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -66.51 -29.96 70.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 50.51 111.223 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -73.52 -13.79 61.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 50.55 111.215 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.4 -45.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 50.51 111.185 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.415 HG23 HG23 ' A' ' 21' ' ' THR . 33.3 m -87.16 -20.02 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 50.51 111.206 -171.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.519 ' HB ' ' CD ' ' A' ' 22' ' ' PRO . 66.6 p -129.58 163.22 48.13 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 50.51 111.248 171.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.519 ' CD ' ' HB ' ' A' ' 21' ' ' THR . 73.5 Cg_exo -54.01 134.46 59.81 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.699 1.599 . . . . 50.51 111.158 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -49.96 119.92 3.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 50.64 111.23 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 97.1 m -115.87 119.79 36.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 50.51 111.218 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 76.3 Cg_exo -54.81 120.07 7.51 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 121.742 1.628 . . . . 50.51 111.129 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.99 143.78 81.47 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.671 1.581 . . . . 50.51 111.219 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.71 155.0 59.23 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.734 1.623 . . . . 50.51 111.211 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.4 p -75.06 166.66 23.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 50.51 111.182 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -75.99 143.33 41.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 50.55 111.19 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.15 -3.8 67.01 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.226 -0.75 . . . . 50.51 111.226 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -90.93 154.94 19.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 50.51 111.206 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.02 161.59 51.02 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.145 -0.782 . . . . 50.51 111.145 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -67.21 -41.56 85.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 50.64 111.22 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -21.18 69.22 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.15 -0.78 . . . . 50.51 111.15 -171.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.07 -27.6 67.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.786 0.326 . . . . 50.51 111.157 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 50.51 111.192 179.619 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.805 0.336 . . . . 50.51 111.222 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -68.36 135.0 51.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 50.55 111.205 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -69.94 168.87 14.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 50.51 111.181 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.47 -177.21 45.74 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.164 -0.774 . . . . 50.51 111.164 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -70.63 169.43 14.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 50.64 111.169 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.2 m -65.02 -34.51 78.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 50.51 111.199 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -80.26 -37.71 32.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 50.55 111.21 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -77.67 -34.99 52.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 50.62 111.225 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -119.62 129.97 54.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 50.62 111.176 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 97.8 m-20 -64.74 140.43 98.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 50.55 111.198 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 10' ' ' ASN . 74.4 Cg_exo -52.29 -36.73 69.11 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.694 1.596 . . . . 50.51 111.169 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.4 t -62.25 -40.02 86.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.239 -0.437 . . . . 50.51 111.146 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 75.7 t -68.07 -41.2 84.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 50.51 111.136 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -54.97 -45.42 74.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 50.51 111.167 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -62.76 -45.65 91.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 50.51 111.218 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -55.0 -50.25 69.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 50.51 111.219 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -61.95 -39.97 93.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 50.51 111.167 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -64.08 -28.23 69.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 50.55 111.157 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.53 -47.31 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 50.51 111.213 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.2 m -90.19 -12.48 9.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.196 -0.457 . . . . 50.51 111.216 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 19.0 p -116.36 165.88 13.93 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 50.51 111.179 172.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 50.1 Cg_exo -51.71 157.72 5.13 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.693 1.595 . . . . 50.51 111.185 171.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -49.84 120.03 4.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 50.64 111.224 -172.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.5 p -97.55 157.33 34.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 50.51 111.265 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.1 163.44 37.72 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.713 1.608 . . . . 50.51 111.186 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.24 161.71 43.72 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.695 1.597 . . . . 50.51 111.168 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.11 173.1 14.21 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.742 1.628 . . . . 50.51 111.164 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.8 p -77.73 169.97 17.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 50.51 111.234 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -66.02 117.07 7.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 50.55 111.196 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.04 -82.09 1.06 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.219 -0.752 . . . . 50.51 111.219 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.81 147.18 23.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.77 0.319 . . . . 50.51 111.231 1.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.87 -161.56 33.26 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.255 -0.738 . . . . 50.51 111.255 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.07 -30.0 55.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 50.64 111.249 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.93 22.42 52.87 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.112 -0.795 . . . . 50.51 111.112 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.5 mt -85.39 148.92 25.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.79 0.329 . . . . 50.51 111.172 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 50.51 111.223 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.829 0.347 . . . . 50.51 111.21 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -51.51 -48.04 63.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 50.55 111.248 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -115.92 -5.01 12.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 50.51 111.231 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.76 -25.6 66.91 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.179 -0.769 . . . . 50.51 111.179 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.64 -24.56 56.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.738 0.304 . . . . 50.64 111.221 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.8 p -85.02 168.86 14.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 50.51 111.163 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -66.36 135.42 54.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 50.55 111.251 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -58.89 118.87 6.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 50.62 111.185 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -91.29 150.18 21.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 50.62 111.189 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -80.11 129.17 70.97 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 50.55 111.179 172.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.78 -23.2 42.11 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.726 1.617 . . . . 50.51 111.176 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.1 t -65.35 -32.15 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 50.51 111.229 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.14 -40.4 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 50.51 111.148 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -76.16 -23.79 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 50.51 111.199 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -70.21 -40.99 74.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 50.51 111.23 171.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -57.06 -44.97 83.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 50.51 111.258 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.54 -37.71 82.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 50.51 111.226 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.0 -32.3 73.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 50.55 111.248 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.0 mt -72.47 -46.14 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 50.51 111.168 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m -90.23 -17.13 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 50.51 111.104 -170.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.3 m -122.24 123.78 27.08 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 50.51 111.205 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -70.16 -27.66 24.31 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.759 1.639 . . . . 50.51 111.182 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -74.97 136.17 41.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 50.64 111.179 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.416 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 88.9 m -58.72 120.07 42.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 50.51 111.24 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 24' ' ' THR . 72.4 Cg_endo -74.79 159.44 42.03 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.648 1.565 . . . . 50.51 111.159 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.06 155.38 69.81 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.712 1.608 . . . . 50.51 111.195 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 36' ' ' SER . 72.8 Cg_endo -73.47 155.77 50.33 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.709 1.606 . . . . 50.51 111.193 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.5 t -63.53 131.65 48.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 50.51 111.17 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -74.39 139.94 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 50.55 111.197 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.73 -148.37 38.28 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.234 -0.746 . . . . 50.51 111.234 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.91 134.29 53.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.824 0.345 . . . . 50.51 111.211 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.24 17.02 30.67 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.26 -0.736 . . . . 50.51 111.26 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -61.66 135.11 57.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.896 0.379 . . . . 50.64 111.166 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.31 -166.38 40.85 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.194 -0.762 . . . . 50.51 111.194 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.1 mt -104.3 2.35 31.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.771 0.32 . . . . 50.51 111.183 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 37.6 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 50.51 111.266 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.459 -0.557 0 N-CA-C 111.146 -0.367 . . . . 50.509999999999998 111.146 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.97 -42.17 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 50.509999999999998 111.211 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.5 -39.84 86.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 50.509999999999998 111.191 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -58.48 -45.08 89.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 50.509999999999998 111.217 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -63.47 -42.36 98.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 50.509999999999998 111.15 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -55.35 -48.87 73.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 50.509999999999998 111.18 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.98 -31.87 73.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 50.509999999999998 111.179 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -60.76 -35.06 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 50.549999999999997 111.167 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.06 -45.02 31.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 50.509999999999998 111.235 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 50.509999999999998 111.188 -168.207 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo . . . . . 0 N--CA 1.458 -0.605 0 N-CA-C 111.232 -0.334 . . . . 50.509999999999998 111.232 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.1 t -69.12 -39.91 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 50.509999999999998 111.19 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.5 t -62.36 -42.82 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 50.509999999999998 111.179 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -62.83 -39.79 95.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 50.509999999999998 111.237 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -58.66 -44.59 90.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 50.509999999999998 111.21 174.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -64.04 -37.28 86.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 50.509999999999998 111.227 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -70.78 -28.56 64.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 50.509999999999998 111.14 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -74.99 -9.47 58.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 50.549999999999997 111.196 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.4 -45.45 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 50.509999999999998 111.212 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 50.509999999999998 111.205 -172.701 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 N--CA 1.458 -0.587 0 N-CA-C 111.213 -0.341 . . . . 50.509999999999998 111.213 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.57 -40.09 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 50.509999999999998 111.16 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.9 t -62.72 -39.93 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 50.509999999999998 111.211 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -73.23 -29.3 62.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 50.509999999999998 111.188 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -59.53 -50.24 74.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 50.509999999999998 111.206 172.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -55.51 -49.91 71.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 50.509999999999998 111.189 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -64.98 -30.27 71.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 50.509999999999998 111.19 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -65.74 -29.98 70.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 50.549999999999997 111.179 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.1 -45.05 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 50.509999999999998 111.298 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 50.509999999999998 111.203 -170.636 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 N--CA 1.457 -0.619 0 N-CA-C 111.206 -0.344 . . . . 50.509999999999998 111.206 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.2 t -70.55 -41.36 78.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 50.509999999999998 111.194 173.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.35 -40.06 87.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 50.509999999999998 111.226 173.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -59.92 -45.26 93.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 50.509999999999998 111.261 175.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -55.51 -50.8 69.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 50.509999999999998 111.211 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.71 -49.63 76.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 50.509999999999998 111.217 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -69.25 -27.26 65.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 50.509999999999998 111.16 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -75.53 -7.68 54.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 50.549999999999997 111.206 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.51 -47.81 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 50.509999999999998 111.169 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 50.509999999999998 111.125 -174.725 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo . . . . . 0 N--CA 1.458 -0.588 0 N-CA-C 111.19 -0.35 . . . . 50.509999999999998 111.19 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.03 -39.93 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 50.509999999999998 111.235 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.0 t -69.86 -36.71 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.286 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -59.57 -43.87 93.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 50.509999999999998 111.2 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -59.57 -45.93 90.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 50.509999999999998 111.161 173.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -55.01 -45.05 75.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 50.509999999999998 111.189 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.9 -34.76 78.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 50.509999999999998 111.233 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -59.87 -34.7 73.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 50.549999999999997 111.173 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.87 -43.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 50.509999999999998 111.189 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.5 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 50.509999999999998 111.153 -171.305 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 N--CA 1.458 -0.603 0 N-CA-C 111.19 -0.35 . . . . 50.509999999999998 111.19 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.58 -40.94 85.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 50.509999999999998 111.186 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.86 -41.15 91.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 50.509999999999998 111.263 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -65.77 -36.56 83.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 50.509999999999998 111.23 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -56.27 -50.7 70.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 50.509999999999998 111.196 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -57.36 -48.58 78.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 50.509999999999998 111.234 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -65.03 -30.41 71.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 50.509999999999998 111.222 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.0 -12.17 60.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 50.549999999999997 111.23 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 94.7 mt -90.83 -44.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 50.509999999999998 111.143 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 50.509999999999998 111.143 -174.78 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo . . . . . 0 N--CA 1.459 -0.539 0 N-CA-C 111.218 -0.339 . . . . 50.509999999999998 111.218 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.3 t -69.97 -45.09 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 50.509999999999998 111.144 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.56 -38.51 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 50.509999999999998 111.201 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -65.21 -40.09 93.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 50.509999999999998 111.173 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.42 -47.16 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 50.509999999999998 111.21 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -56.26 -47.94 77.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 50.509999999999998 111.154 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -60.25 -33.92 72.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 50.509999999999998 111.273 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.41 -34.41 76.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 50.549999999999997 111.212 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.09 -47.93 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.188 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.0 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 50.509999999999998 111.195 -171.807 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.458 -0.576 0 N-CA-C 111.173 -0.357 . . . . 50.509999999999998 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.92 -40.23 76.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 50.509999999999998 111.17 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.32 -39.92 87.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.231 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -60.59 -47.09 87.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 50.509999999999998 111.184 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -55.96 -52.22 64.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.232 176.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -51.74 -50.63 60.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 50.509999999999998 111.208 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -66.51 -29.96 70.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 50.509999999999998 111.223 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -73.52 -13.79 61.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 50.549999999999997 111.215 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.4 -45.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.185 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 50.509999999999998 111.206 -171.436 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo . . . . . 0 N--CA 1.458 -0.586 0 N-CA-C 111.169 -0.358 . . . . 50.509999999999998 111.169 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.4 t -62.25 -40.02 86.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.239 -0.437 . . . . 50.509999999999998 111.146 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 75.7 t -68.07 -41.2 84.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 50.509999999999998 111.136 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -54.97 -45.42 74.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 50.509999999999998 111.167 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -62.76 -45.65 91.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 50.509999999999998 111.218 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -55.0 -50.25 69.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 50.509999999999998 111.219 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -61.95 -39.97 93.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.167 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -64.08 -28.23 69.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 50.549999999999997 111.157 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.53 -47.31 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 50.509999999999998 111.213 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.2 m . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.196 -0.457 . . . . 50.509999999999998 111.216 -168.639 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 N--CA 1.459 -0.533 0 N-CA-C 111.176 -0.356 . . . . 50.509999999999998 111.176 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.1 t -65.35 -32.15 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 50.509999999999998 111.229 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.14 -40.4 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 50.509999999999998 111.148 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -76.16 -23.79 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 50.509999999999998 111.199 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -70.21 -40.99 74.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 50.509999999999998 111.23 171.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -57.06 -44.97 83.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 50.509999999999998 111.258 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.54 -37.71 82.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 50.509999999999998 111.226 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.0 -32.3 73.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 50.549999999999997 111.248 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.0 mt -72.47 -46.14 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 50.509999999999998 111.168 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 50.509999999999998 111.104 -170.01 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.812 0.339 . . . . 50.509999999999998 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -100.09 160.04 14.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 50.549999999999997 111.211 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -103.48 145.36 30.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 50.509999999999998 111.177 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.87 -161.77 33.88 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.2 -0.76 . . . . 50.509999999999998 111.2 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -105.74 13.8 29.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.343 . . . . 50.640000000000001 111.229 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.521 ' HB ' ' HG3' ' A' ' 29' ' ' GLN . 91.9 m -99.34 139.99 34.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 50.509999999999998 111.208 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.23 139.79 58.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 50.549999999999997 111.204 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -46.82 110.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 50.619999999999997 111.228 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -74.36 130.1 39.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 50.619999999999997 111.183 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -75.07 148.95 84.75 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 50.549999999999997 111.21 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.86 -28.2 75.51 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.691 1.594 . . . . 50.509999999999998 111.146 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.97 -42.17 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 50.509999999999998 111.211 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.5 -39.84 86.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 50.509999999999998 111.191 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -58.48 -45.08 89.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 50.509999999999998 111.217 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -63.47 -42.36 98.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 50.509999999999998 111.15 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -55.35 -48.87 73.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 50.509999999999998 111.18 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.98 -31.87 73.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 50.509999999999998 111.179 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -60.76 -35.06 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 50.549999999999997 111.167 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.06 -45.02 31.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 50.509999999999998 111.235 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 m -96.08 -16.91 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 50.509999999999998 111.188 -168.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.407 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 85.9 m -126.83 120.12 22.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 50.509999999999998 111.192 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 21' ' ' THR . 56.1 Cg_endo -71.91 -25.1 20.24 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.672 1.581 . . . . 50.509999999999998 111.235 -177.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.15 139.72 41.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 50.640000000000001 111.26 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 91.5 m -56.59 117.58 17.76 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 50.509999999999998 111.184 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 41.4 Cg_exo -59.59 156.81 34.93 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.734 1.623 . . . . 50.509999999999998 111.172 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.56 154.87 72.35 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.701 1.601 . . . . 50.509999999999998 111.213 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.49 158.54 50.94 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.718 1.612 . . . . 50.509999999999998 111.198 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.1 m -68.73 144.17 54.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 50.509999999999998 111.205 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.521 ' HG3' ' HB ' ' A' ' 6' ' ' THR . 89.4 mm-40 -104.97 161.92 13.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 50.549999999999997 111.223 -176.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.81 147.81 43.15 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.19 -0.764 . . . . 50.509999999999998 111.19 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.1 121.41 14.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.809 0.337 . . . . 50.509999999999998 111.172 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.71 -5.05 56.6 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.203 -0.759 . . . . 50.509999999999998 111.203 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -67.23 -29.28 68.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.772 0.32 . . . . 50.640000000000001 111.186 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.73 -37.44 94.35 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.212 -0.755 . . . . 50.509999999999998 111.212 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.15 -31.99 38.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.74 0.305 . . . . 50.509999999999998 111.174 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.2 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 50.509999999999998 111.184 178.198 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.865 0.364 . . . . 50.509999999999998 111.219 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -98.12 159.26 15.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 50.549999999999997 111.226 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -66.39 136.82 56.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.208 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.49 -165.09 32.12 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.224 -0.75 . . . . 50.509999999999998 111.224 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.418 ' HG2' ' H ' ' A' ' 7' ' ' GLN . 64.4 ttt180 -98.08 127.32 43.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 50.640000000000001 111.23 -177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.6 p -77.24 -17.16 58.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 50.509999999999998 111.19 -174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.418 ' H ' ' HG2' ' A' ' 5' ' ' ARG . 98.0 mm-40 -84.81 -36.47 21.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 50.549999999999997 111.197 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -95.1 -32.37 13.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 50.619999999999997 111.208 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -110.12 136.1 49.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 50.619999999999997 111.164 -175.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -67.89 150.11 97.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 50.549999999999997 111.212 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.06 -24.38 76.54 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.721 1.614 . . . . 50.509999999999998 111.232 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.1 t -69.12 -39.91 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 50.509999999999998 111.19 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.5 t -62.36 -42.82 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 50.509999999999998 111.179 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -62.83 -39.79 95.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 50.509999999999998 111.237 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -58.66 -44.59 90.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 50.509999999999998 111.21 174.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -64.04 -37.28 86.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 50.509999999999998 111.227 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -70.78 -28.56 64.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 50.509999999999998 111.14 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -74.99 -9.47 58.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 50.549999999999997 111.196 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.4 -45.45 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 50.509999999999998 111.212 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.433 HG23 HG23 ' A' ' 21' ' ' THR . 34.2 m -87.52 -20.41 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 50.509999999999998 111.205 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.503 ' HB ' ' CD ' ' A' ' 22' ' ' PRO . 82.1 p -128.65 163.31 45.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 50.509999999999998 111.165 171.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.503 ' CD ' ' HB ' ' A' ' 21' ' ' THR . 74.8 Cg_exo -53.72 147.25 41.11 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.685 1.59 . . . . 50.509999999999998 111.235 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -45.63 129.8 8.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 50.640000000000001 111.211 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.7 p -83.83 154.78 64.83 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 50.509999999999998 111.204 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.15 167.77 26.47 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.733 1.622 . . . . 50.509999999999998 111.162 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.33 159.18 20.07 Favored 'Trans proline' 0 C--N 1.328 -0.543 0 C-N-CA 121.724 1.616 . . . . 50.509999999999998 111.169 175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.51 144.98 39.15 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.642 1.561 . . . . 50.509999999999998 111.24 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.3 m -95.84 130.03 42.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 50.509999999999998 111.224 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -74.96 123.93 26.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 50.549999999999997 111.232 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.5 22.28 58.75 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.218 -0.753 . . . . 50.509999999999998 111.218 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -119.84 20.43 12.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 50.509999999999998 111.179 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.07 -3.0 66.5 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.248 -0.741 . . . . 50.509999999999998 111.248 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -79.76 -25.97 40.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.359 . . . . 50.640000000000001 111.179 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.03 15.9 66.23 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.222 -0.751 . . . . 50.509999999999998 111.222 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.1 tp -67.49 121.57 16.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.76 0.314 . . . . 50.509999999999998 111.215 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.9 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 50.509999999999998 111.252 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.813 0.339 . . . . 50.509999999999998 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -67.4 112.38 4.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 50.549999999999997 111.155 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -73.88 124.19 25.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 50.509999999999998 111.22 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.99 -152.69 29.64 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.226 -0.75 . . . . 50.509999999999998 111.226 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -84.93 144.72 28.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.776 0.322 . . . . 50.640000000000001 111.225 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.4 p -85.35 152.08 23.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.2 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.572 ' HB3' ' HG3' ' A' ' 29' ' ' GLN . 92.6 mm-40 -83.95 146.65 27.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 50.549999999999997 111.246 -5.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -75.43 172.83 11.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 50.619999999999997 111.235 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.97 159.89 16.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 50.619999999999997 111.199 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -64.01 147.47 96.41 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 50.549999999999997 111.251 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -62.33 -25.04 76.22 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.735 1.623 . . . . 50.509999999999998 111.213 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.57 -40.09 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 50.509999999999998 111.16 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 68.9 t -62.72 -39.93 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 50.509999999999998 111.211 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -73.23 -29.3 62.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 50.509999999999998 111.188 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -59.53 -50.24 74.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 50.509999999999998 111.206 172.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -55.51 -49.91 71.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 50.509999999999998 111.189 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -64.98 -30.27 71.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 50.509999999999998 111.19 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -65.74 -29.98 70.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 50.549999999999997 111.179 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.1 -45.05 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 50.509999999999998 111.298 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.5 m -91.66 -15.74 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 50.509999999999998 111.203 -170.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.8 m -126.56 124.53 24.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 50.509999999999998 111.258 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.09 -25.98 21.95 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.672 1.581 . . . . 50.509999999999998 111.193 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.04 135.17 47.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 50.640000000000001 111.195 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.473 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 65.5 m -59.72 119.82 44.0 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 50.509999999999998 111.118 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 53.0 Cg_exo -59.0 154.96 41.54 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.77 1.647 . . . . 50.509999999999998 111.167 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 53.2 Cg_exo -55.66 162.1 6.99 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.702 1.602 . . . . 50.509999999999998 111.217 176.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.02 147.8 51.13 Favored 'Trans proline' 0 C--N 1.328 -0.543 0 C-N-CA 121.71 1.606 . . . . 50.509999999999998 111.183 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 94.3 p -82.61 165.01 20.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 50.509999999999998 111.21 -174.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.572 ' HG3' ' HB3' ' A' ' 7' ' ' GLN . 43.9 tt0 -47.36 127.02 10.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 50.549999999999997 111.14 175.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.64 -45.83 95.6 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.157 -0.777 . . . . 50.509999999999998 111.157 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.03 -34.79 78.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 50.509999999999998 111.232 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.71 -28.04 69.85 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.208 -0.757 . . . . 50.509999999999998 111.208 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -78.44 -35.06 47.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.822 0.344 . . . . 50.640000000000001 111.233 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.13 19.96 6.95 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.199 -0.76 . . . . 50.509999999999998 111.199 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -107.69 153.9 22.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.756 0.312 . . . . 50.509999999999998 111.217 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.447 . . . . 50.509999999999998 111.209 179.22 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.9 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.854 0.359 . . . . 50.509999999999998 111.203 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.461 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 65.2 tt0 -68.65 128.76 37.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 50.549999999999997 111.184 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -63.01 134.98 57.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 50.509999999999998 111.174 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.43 176.0 48.36 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.21 -0.756 . . . . 50.509999999999998 111.21 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 61.6 ttm-85 -59.95 125.64 24.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.856 0.36 . . . . 50.640000000000001 111.224 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 77.2 p -77.85 160.9 28.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 50.509999999999998 111.176 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -124.48 98.56 5.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 50.549999999999997 111.222 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.9 t0 52.6 46.37 26.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 50.619999999999997 111.183 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -100.02 158.97 15.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 50.619999999999997 111.202 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -70.75 148.85 95.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 50.549999999999997 111.181 -173.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.49 -24.99 55.9 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.685 1.59 . . . . 50.509999999999998 111.206 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.2 t -70.55 -41.36 78.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 50.509999999999998 111.194 173.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.35 -40.06 87.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 50.509999999999998 111.226 173.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -59.92 -45.26 93.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 50.509999999999998 111.261 175.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -55.51 -50.8 69.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 50.509999999999998 111.211 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.71 -49.63 76.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 50.509999999999998 111.217 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -69.25 -27.26 65.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 50.509999999999998 111.16 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -75.53 -7.68 54.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 50.549999999999997 111.206 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.51 -47.81 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 50.509999999999998 111.169 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.87 -22.23 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 50.509999999999998 111.125 -174.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.464 ' HB ' ' CD ' ' A' ' 22' ' ' PRO . 82.3 p -133.51 163.47 50.86 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.203 172.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.464 ' CD ' ' HB ' ' A' ' 21' ' ' THR . 50.2 Cg_exo -54.15 152.72 23.75 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.786 1.657 . . . . 50.509999999999998 111.185 175.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -49.95 122.51 6.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 50.640000000000001 111.23 -172.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.5 t -89.93 131.8 38.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 50.509999999999998 111.204 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.7 138.2 84.18 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.696 1.597 . . . . 50.509999999999998 111.201 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 74.0 Cg_endo -75.66 161.66 36.49 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.739 1.626 . . . . 50.509999999999998 111.216 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 26' ' ' PRO . 31.5 Cg_exo -61.6 153.82 64.22 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.699 1.599 . . . . 50.509999999999998 111.208 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.1 p -79.99 170.08 16.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 50.509999999999998 111.183 174.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -78.68 150.04 32.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 50.549999999999997 111.157 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.95 -3.3 67.08 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.266 -0.733 . . . . 50.509999999999998 111.266 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -99.57 -3.89 32.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 50.509999999999998 111.165 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.36 -5.97 45.45 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.257 -0.737 . . . . 50.509999999999998 111.257 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -64.68 -44.96 88.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 50.640000000000001 111.244 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.3 -27.19 72.07 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.194 -0.762 . . . . 50.509999999999998 111.194 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.52 -29.99 52.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.795 0.331 . . . . 50.509999999999998 111.171 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.0 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 50.509999999999998 111.224 178.694 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 99.9 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.787 0.327 . . . . 50.509999999999998 111.158 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -69.5 150.05 47.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 50.549999999999997 111.209 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.402 ' HA ' ' H ' ' A' ' 32' ' ' GLY . 52.8 p-80 -74.97 160.59 30.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 50.509999999999998 111.244 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.88 -83.89 1.0 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.209 -0.756 . . . . 50.509999999999998 111.209 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -89.97 139.82 30.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 50.640000000000001 111.2 4.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 67.2 p -133.32 170.08 15.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 50.509999999999998 111.243 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -79.95 129.96 34.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 50.549999999999997 111.131 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -73.29 111.12 8.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 50.619999999999997 111.231 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -75.0 145.39 42.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 50.619999999999997 111.135 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.446 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 55.5 t-20 -75.01 119.64 77.88 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 50.549999999999997 111.165 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 10' ' ' ASN . 71.3 Cg_exo -53.59 -31.73 60.92 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.713 1.609 . . . . 50.509999999999998 111.19 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.03 -39.93 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 50.509999999999998 111.235 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.0 t -69.86 -36.71 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.286 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -59.57 -43.87 93.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 50.509999999999998 111.2 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -59.57 -45.93 90.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 50.509999999999998 111.161 173.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -55.01 -45.05 75.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 50.509999999999998 111.189 174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.9 -34.76 78.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 50.509999999999998 111.233 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -59.87 -34.7 73.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 50.549999999999997 111.173 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.87 -43.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 50.509999999999998 111.189 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.5 t -92.58 -62.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 50.509999999999998 111.153 -171.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.408 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 98.4 m -78.58 123.91 85.43 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 50.509999999999998 111.12 -172.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 21' ' ' THR . 63.9 Cg_endo -72.41 143.08 38.12 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.714 1.609 . . . . 50.509999999999998 111.182 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 55.53 52.79 10.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 50.640000000000001 111.238 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.407 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 95.6 m -81.8 121.4 79.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 50.509999999999998 111.176 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 24' ' ' THR . 71.6 Cg_endo -76.32 165.47 29.27 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.702 1.601 . . . . 50.509999999999998 111.209 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.05 145.93 61.2 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.713 1.608 . . . . 50.509999999999998 111.186 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.51 140.34 32.91 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.714 1.609 . . . . 50.509999999999998 111.135 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 99.8 p -73.55 155.19 39.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 50.509999999999998 111.238 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -114.58 173.1 6.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.418 . . . . 50.549999999999997 111.217 -169.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.16 -164.96 38.27 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.153 -0.779 . . . . 50.509999999999998 111.153 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.07 125.04 22.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 50.509999999999998 111.198 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.402 ' H ' ' HA ' ' A' ' 3' ' ' HIS . . . -102.92 -138.31 9.91 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.211 -0.756 . . . . 50.509999999999998 111.211 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -145.32 115.12 7.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.826 0.345 . . . . 50.640000000000001 111.193 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.0 -21.53 67.88 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.198 -0.761 . . . . 50.509999999999998 111.198 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.96 -16.33 41.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 50.509999999999998 111.203 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 50.509999999999998 111.143 -178.715 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.805 0.336 . . . . 50.509999999999998 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -77.52 163.37 26.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 50.549999999999997 111.241 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -65.97 147.3 53.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.3 -0.409 . . . . 50.509999999999998 111.191 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.22 175.21 42.72 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.211 -0.755 . . . . 50.509999999999998 111.211 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -90.46 135.3 33.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.777 0.323 . . . . 50.640000000000001 111.156 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.3 m -65.57 -34.52 78.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.177 -0.465 . . . . 50.509999999999998 111.176 -175.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -67.44 -35.8 79.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 50.549999999999997 111.208 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -77.74 -41.73 36.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 50.619999999999997 111.16 -173.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -125.74 152.32 45.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 50.619999999999997 111.172 -175.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -66.62 146.61 99.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 50.549999999999997 111.206 -175.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.98 -24.75 59.89 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.764 1.643 . . . . 50.509999999999998 111.19 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.2 t -67.58 -40.94 85.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 50.509999999999998 111.186 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.86 -41.15 91.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 50.509999999999998 111.263 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -65.77 -36.56 83.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 50.509999999999998 111.23 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -56.27 -50.7 70.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 50.509999999999998 111.196 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -57.36 -48.58 78.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 50.509999999999998 111.234 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -65.03 -30.41 71.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 50.509999999999998 111.222 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.0 -12.17 60.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 50.549999999999997 111.23 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 94.7 mt -90.83 -44.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 50.509999999999998 111.143 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m -88.91 -14.16 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 50.509999999999998 111.143 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.1 m -125.31 129.82 24.34 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.282 -0.417 . . . . 50.509999999999998 111.248 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.63 174.24 10.55 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.729 1.619 . . . . 50.509999999999998 111.148 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -59.81 120.12 8.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 50.640000000000001 111.201 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.633 ' HB ' ' CD ' ' A' ' 25' ' ' PRO . 76.7 p -127.98 166.09 26.11 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 50.509999999999998 111.184 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.633 ' CD ' ' HB ' ' A' ' 24' ' ' THR . 87.9 Cg_exo -53.16 145.3 43.86 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.716 1.61 . . . . 50.509999999999998 111.19 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.45 166.01 30.98 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.703 1.602 . . . . 50.509999999999998 111.212 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.96 169.11 22.96 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.698 1.599 . . . . 50.509999999999998 111.186 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.0 t -60.01 148.33 35.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 50.509999999999998 111.236 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -45.45 120.0 2.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 50.549999999999997 111.23 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.05 -82.07 1.06 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.19 -0.764 . . . . 50.509999999999998 111.19 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -98.88 158.25 15.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.723 0.297 . . . . 50.509999999999998 111.274 2.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.68 -164.64 32.97 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.243 -0.743 . . . . 50.509999999999998 111.243 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -80.12 -20.02 45.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 50.640000000000001 111.151 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.42 43.76 5.76 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.217 -0.753 . . . . 50.509999999999998 111.217 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.4 mt -114.49 -17.36 11.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 50.509999999999998 111.169 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 50.509999999999998 111.23 178.614 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.877 0.37 . . . . 50.509999999999998 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.4 tp60 -73.07 129.77 38.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 50.549999999999997 111.217 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -112.42 170.02 8.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 50.509999999999998 111.199 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.03 152.43 43.83 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.143 -0.783 . . . . 50.509999999999998 111.143 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -76.88 -23.45 52.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 50.640000000000001 111.188 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 81.4 p -114.46 -10.61 12.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 50.509999999999998 111.256 175.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -99.97 -3.8 31.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 50.549999999999997 111.163 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -64.94 114.97 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 50.619999999999997 111.215 176.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -65.3 145.02 56.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 50.619999999999997 111.182 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.482 ' OD1' ' HD2' ' A' ' 11' ' ' PRO . 57.5 t-20 -54.07 120.88 26.97 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.492 . . . . 50.549999999999997 111.164 176.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 10' ' ' ASN . 88.2 Cg_exo -52.03 -35.0 59.63 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.629 1.553 . . . . 50.509999999999998 111.218 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.3 t -69.97 -45.09 77.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 50.509999999999998 111.144 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.56 -38.51 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 50.509999999999998 111.201 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -65.21 -40.09 93.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 50.509999999999998 111.173 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.42 -47.16 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 50.509999999999998 111.21 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -56.26 -47.94 77.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 50.509999999999998 111.154 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -60.25 -33.92 72.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 50.509999999999998 111.273 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.41 -34.41 76.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 50.549999999999997 111.212 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.09 -47.93 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.188 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.0 m -90.77 -19.94 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 50.509999999999998 111.195 -171.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.1 m -133.97 93.39 20.34 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 50.509999999999998 111.218 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -57.09 -27.68 75.2 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.692 1.595 . . . . 50.509999999999998 111.213 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -109.95 30.72 6.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 50.640000000000001 111.189 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -64.21 140.06 97.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 50.509999999999998 111.223 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.64 154.22 64.4 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.733 1.622 . . . . 50.509999999999998 111.184 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.6 171.45 18.14 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.677 1.584 . . . . 50.509999999999998 111.2 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -51.44 142.93 36.91 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.71 1.607 . . . . 50.509999999999998 111.23 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -75.06 151.11 38.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 50.509999999999998 111.126 -170.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -89.98 160.04 16.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 50.549999999999997 111.197 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.8 -153.26 30.12 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.171 -0.772 . . . . 50.509999999999998 111.171 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.11 -20.86 57.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 50.509999999999998 111.159 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.79 -178.61 51.65 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.202 -0.759 . . . . 50.509999999999998 111.202 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.35 152.5 26.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 50.640000000000001 111.194 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.06 -17.01 79.39 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.166 -0.773 . . . . 50.509999999999998 111.166 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.6 mt -96.99 -2.72 42.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.801 0.334 . . . . 50.509999999999998 111.186 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.22 -178.244 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.77 0.319 . . . . 50.509999999999998 111.19 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -70.03 127.94 34.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 50.549999999999997 111.207 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -55.51 128.49 34.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 50.509999999999998 111.206 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.72 -155.07 31.05 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.188 -0.765 . . . . 50.509999999999998 111.188 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -92.36 142.85 26.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 50.640000000000001 111.19 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.5 m -58.12 -40.3 80.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 50.509999999999998 111.169 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -74.9 -40.21 61.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 50.549999999999997 111.154 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -69.98 -49.78 48.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.416 . . . . 50.619999999999997 111.155 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -91.06 153.25 20.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 50.619999999999997 111.177 -166.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -75.71 150.12 83.88 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 50.549999999999997 111.177 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.75 -25.62 74.92 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.77 1.647 . . . . 50.509999999999998 111.173 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.9 t -70.92 -40.23 76.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 50.509999999999998 111.17 173.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.32 -39.92 87.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.231 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -60.59 -47.09 87.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 50.509999999999998 111.184 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -55.96 -52.22 64.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.232 176.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -51.74 -50.63 60.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 50.509999999999998 111.208 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -66.51 -29.96 70.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 50.509999999999998 111.223 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -73.52 -13.79 61.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 50.549999999999997 111.215 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.4 -45.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 50.509999999999998 111.185 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.415 HG23 HG23 ' A' ' 21' ' ' THR . 33.3 m -87.16 -20.02 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 50.509999999999998 111.206 -171.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.519 ' HB ' ' CD ' ' A' ' 22' ' ' PRO . 66.6 p -129.58 163.22 48.13 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 50.509999999999998 111.248 171.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.519 ' CD ' ' HB ' ' A' ' 21' ' ' THR . 73.5 Cg_exo -54.01 134.46 59.81 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.699 1.599 . . . . 50.509999999999998 111.158 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -49.96 119.92 3.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 50.640000000000001 111.23 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 97.1 m -115.87 119.79 36.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 50.509999999999998 111.218 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 76.3 Cg_exo -54.81 120.07 7.51 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 121.742 1.628 . . . . 50.509999999999998 111.129 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.99 143.78 81.47 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.671 1.581 . . . . 50.509999999999998 111.219 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.71 155.0 59.23 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.734 1.623 . . . . 50.509999999999998 111.211 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.4 p -75.06 166.66 23.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 50.509999999999998 111.182 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -75.99 143.33 41.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 50.549999999999997 111.19 -178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.15 -3.8 67.01 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.226 -0.75 . . . . 50.509999999999998 111.226 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -90.93 154.94 19.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 50.509999999999998 111.206 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.02 161.59 51.02 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.145 -0.782 . . . . 50.509999999999998 111.145 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -67.21 -41.56 85.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 50.640000000000001 111.22 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -21.18 69.22 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.15 -0.78 . . . . 50.509999999999998 111.15 -171.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.07 -27.6 67.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.786 0.326 . . . . 50.509999999999998 111.157 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 50.509999999999998 111.192 179.619 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.805 0.336 . . . . 50.509999999999998 111.222 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -68.36 135.0 51.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 50.549999999999997 111.205 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -69.94 168.87 14.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 50.509999999999998 111.181 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.47 -177.21 45.74 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.164 -0.774 . . . . 50.509999999999998 111.164 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -70.63 169.43 14.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 50.640000000000001 111.169 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.2 m -65.02 -34.51 78.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 50.509999999999998 111.199 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -80.26 -37.71 32.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 50.549999999999997 111.21 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -77.67 -34.99 52.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 50.619999999999997 111.225 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -119.62 129.97 54.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 50.619999999999997 111.176 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 97.8 m-20 -64.74 140.43 98.05 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 50.549999999999997 111.198 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 10' ' ' ASN . 74.4 Cg_exo -52.29 -36.73 69.11 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.694 1.596 . . . . 50.509999999999998 111.169 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.4 t -62.25 -40.02 86.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.239 -0.437 . . . . 50.509999999999998 111.146 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 75.7 t -68.07 -41.2 84.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 50.509999999999998 111.136 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -54.97 -45.42 74.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 50.509999999999998 111.167 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -62.76 -45.65 91.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 50.509999999999998 111.218 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -55.0 -50.25 69.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 50.509999999999998 111.219 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -61.95 -39.97 93.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 50.509999999999998 111.167 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -64.08 -28.23 69.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 50.549999999999997 111.157 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.53 -47.31 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 50.509999999999998 111.213 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.2 m -90.19 -12.48 9.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.196 -0.457 . . . . 50.509999999999998 111.216 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 22' ' ' PRO . 19.0 p -116.36 165.88 13.93 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 50.509999999999998 111.179 172.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 21' ' ' THR . 50.1 Cg_exo -51.71 157.72 5.13 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.693 1.595 . . . . 50.509999999999998 111.185 171.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -49.84 120.03 4.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 50.640000000000001 111.224 -172.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.5 p -97.55 157.33 34.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 50.509999999999998 111.265 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.1 163.44 37.72 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.713 1.608 . . . . 50.509999999999998 111.186 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.24 161.71 43.72 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.695 1.597 . . . . 50.509999999999998 111.168 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.11 173.1 14.21 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.742 1.628 . . . . 50.509999999999998 111.164 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.8 p -77.73 169.97 17.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 50.509999999999998 111.234 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -66.02 117.07 7.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 50.549999999999997 111.196 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.04 -82.09 1.06 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.219 -0.752 . . . . 50.509999999999998 111.219 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -95.81 147.18 23.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.77 0.319 . . . . 50.509999999999998 111.231 1.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.87 -161.56 33.26 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.255 -0.738 . . . . 50.509999999999998 111.255 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.07 -30.0 55.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 50.640000000000001 111.249 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.93 22.42 52.87 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.112 -0.795 . . . . 50.509999999999998 111.112 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.5 mt -85.39 148.92 25.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.79 0.329 . . . . 50.509999999999998 111.172 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 50.509999999999998 111.223 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.829 0.347 . . . . 50.509999999999998 111.21 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -51.51 -48.04 63.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 50.549999999999997 111.248 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -115.92 -5.01 12.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 50.509999999999998 111.231 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.76 -25.6 66.91 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.179 -0.769 . . . . 50.509999999999998 111.179 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.64 -24.56 56.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.738 0.304 . . . . 50.640000000000001 111.221 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.8 p -85.02 168.86 14.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 50.509999999999998 111.163 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -66.36 135.42 54.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 50.549999999999997 111.251 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -58.89 118.87 6.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 50.619999999999997 111.185 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -91.29 150.18 21.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 50.619999999999997 111.189 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -80.11 129.17 70.97 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 50.549999999999997 111.179 172.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.78 -23.2 42.11 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 121.726 1.617 . . . . 50.509999999999998 111.176 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.1 t -65.35 -32.15 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 50.509999999999998 111.229 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.14 -40.4 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 50.509999999999998 111.148 175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -76.16 -23.79 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 50.509999999999998 111.199 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -70.21 -40.99 74.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 50.509999999999998 111.23 171.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -57.06 -44.97 83.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 50.509999999999998 111.258 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.54 -37.71 82.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 50.509999999999998 111.226 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.0 -32.3 73.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 50.549999999999997 111.248 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.0 mt -72.47 -46.14 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 50.509999999999998 111.168 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.9 m -90.23 -17.13 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 50.509999999999998 111.104 -170.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.3 m -122.24 123.78 27.08 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 50.509999999999998 111.205 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -70.16 -27.66 24.31 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.759 1.639 . . . . 50.509999999999998 111.182 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -74.97 136.17 41.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 50.640000000000001 111.179 175.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.416 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 88.9 m -58.72 120.07 42.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 50.509999999999998 111.24 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 24' ' ' THR . 72.4 Cg_endo -74.79 159.44 42.03 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.648 1.565 . . . . 50.509999999999998 111.159 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.06 155.38 69.81 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.712 1.608 . . . . 50.509999999999998 111.195 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 36' ' ' SER . 72.8 Cg_endo -73.47 155.77 50.33 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.709 1.606 . . . . 50.509999999999998 111.193 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.5 t -63.53 131.65 48.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 50.509999999999998 111.17 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -74.39 139.94 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 50.549999999999997 111.197 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.73 -148.37 38.28 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.234 -0.746 . . . . 50.509999999999998 111.234 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.91 134.29 53.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.824 0.345 . . . . 50.509999999999998 111.211 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.24 17.02 30.67 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.26 -0.736 . . . . 50.509999999999998 111.26 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -61.66 135.11 57.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.896 0.379 . . . . 50.640000000000001 111.166 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.31 -166.38 40.85 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.194 -0.762 . . . . 50.509999999999998 111.194 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.1 mt -104.3 2.35 31.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.771 0.32 . . . . 50.509999999999998 111.183 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 37.6 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 50.509999999999998 111.266 179.924 . . . . . . . . 1 1 . 1 stop_ save_